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Abstract 
Obstructive sleep apnoea (OSA) is a serious form of sleep-disordered
breathing (SDB). OSA is associated with cardiovascular disease,
compromises driving safety and increases the risk of peri-surgery
complications. Reports suggest that many people with OSA, even those with
obesity, remain undiagnosed. Adherence to the treatment of continuous 
positive airway pressure can be poor. Emerging research points towards an
inverse association between physical activity and severity of SDB. Therefore,
the work in this thesis involved various studies relevant to the role of physical
activity in the diagnosis and treatment of OSA.
In the diagnostic pathway, the first study examined the association between 
self-reported slow-walking speed (an indicator of frailty) and SDB in the
large, cross-sectional Multi-Ethnic Study of Atherosclerosis (MESA). The
95% CI risk differences (multivariable-adjusted) for slow vs. faster walking
speed were: sleep apnoea (0.4-2.5%), self-reported apnoeas (0.1-3.8%),
loud snoring (1.2-8.3%), and daytime sleepiness (3.0-7.8%). The
multivariable-adjusted risk ratio indicated that slower walkers had 1.5 (95%
CI: 1.0 to 2.1) times the risk of sleep apnoea vs. faster walkers.
In a second study, which involved weight-loss surgery patients, the body
mass index (BMI) item of the STOP-Bang screening tool was replaced with a
slow-walking speed item and improved the area under the receiver operating
characteristic curve for OSA screening from 0.64 to 0.70. A slower walking
speed was also reported significantly more in OSA patients than non-OSA 
patients (% difference, 95% CI: 21.7%, 4.2-36.5%). This prevalence
difference was larger than those observed for any of the STOPANG items.
From these studies, it was concluded that a slow-walking speed question
might help consolidate screening for OSA.
The first study in the treatment pathway of the thesis was a critical analysis 
of published evidence syntheses on exercise as a treatment for the
symptoms of OSA. It was concluded that, despite some variability between 
xv 
  
        
        
        
       
 
           
    
          
          
      
      
         
        
          
        
        
 
        
         
     
        
         
        
          
    
 
 
 
 
 
 
 
 
reviews, especially in meta-analyses (mean AHI reductions between 4.66
and 17.23 events/h reported in RCT-only meta-analyses), exercise has a
clinically meaningful effect on reducing OSA severity and daytime sleepiness 
in adults, independent of BMI changes.
In the context of OSA consequences, the second study conducted in the
treatment pathway assessed whether percentage flow-mediated dilation 
(FMD%), an early indicator of atherosclerosis, is affected by OSA. Using the
MESA dataset, it was found that the sex, race and age-adjusted mean
FMD% was 0.6% lower in participants with physician-diagnosed sleep
apnoea compared to undiagnosed participants. However, this mean 
difference was 0.3% and not statistically significant when the confounding
influence of initial artery diameter was allometrically adjusted for. It was 
therefore concluded that people with OSA do not demonstrate a clinically
important reduction in FMD%. Consequently, this outcome was not included
in the final protocol phase of the thesis.
The final chapter in this thesis presents a protocol for a feasibility study
examining the benefits of exercise for obese people with OSA who undergo
weight-loss surgery. This 12-week aerobic and resistance training protocol
was patient-informed and focused on feasibility, safety and acceptability
outcomes to inform the design of a subsequent definitive randomised
controlled trial. Future work should progress this protocol into the next
research phase to support the optimisation of the clinical pathway for weight-
loss surgery patients with OSA.
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Chapter One: Introduction
1.1 Background and rationale for the research
Obstructive sleep apnoea (OSA) is a severe type of sleep-disordered
breathing (SDB), which is characterised by multiple losses of airway
patency during sleep (Habib and Phillips, 2007). Prevalence rates of OSA 
have been reported between three and 17% in the general population
(Punjabi, 2008; Peppard et al., 2013) and can be greater than 50% in
bariatric groups (Chung, Abdullah and Liao, 2016). This disorder can
pose a serious threat to health, increasing the risk of cardiovascular 
disease and stroke and postoperative complications in undiagnosed
patients who undergo surgery (Lattimore, Celermajer and Wilcox, 2003;
Chung, Abdullah and Liao, 2016). OSA may also have negative
ramifications on an individual’s quality of life and daily functioning,
compromising occupational and educational performance and driving
safety (Stranks and Crowe, 2016).
Importantly, many individuals may be unaware that they have OSA, and 
reports suggest that a substantial number of people with OSA, even those
with obesity, remain formally undiagnosed (Rejon-Parrilla, Garau and
Sussex, 2014; Chung, Abdullah and Liao, 2016). Inherent problems in
current OSA screening questionnaires (e.g. some questions are reliant on
information from a patient’s bed partner, if they do have one) may be a
potential factor contributing to these poor figures (Nagappa et al., 2017a).
Moreover, the ‘gold-standard’ treatment for OSA, continuous positive
airway pressure (CPAP), is not well tolerated by many patients 
(Rotenberg, Murariu and Pang, 2016). Adherence rates for CPAP remain
persistently low over 20 years of data reporting (consistent non-
adherence rates of 30-40%) (Rotenberg, Murariu and Pang, 2016).
Improved screening and alternative management strategies are
undeniably needed to address these problems.
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It is well documented that physical activity levels can reduce the risk and
severity of multiple diseases (World Health Organisation (WHO), 2018). Over 
the past decade, a growing body of research has evolved to suggest that
physical activity may also have benefits for reducing the severity and
symptoms of SDB, independent of changes in body mass index (BMI)
(Peppard and Young, 2004; Iftikhar, Kline and Youngstedt, 2014; Simpson et 
al., 2015; da Silva et al., 2017; Iftikhar et al., 2017; Kline et al., 2017).
Therefore, it is plausible to suggest that physical activity could be used to
improve the diagnosis and treatment of OSA. However, at present there is a
need for further work to expand the evidence base regarding a) the effects of
exercise (a sub-category of physical activity) on the severity and symptoms 
of OSA and b) the mechanisms responsible for the beneficial effects of
exercise on the disorder (Iftikhar et al., 2017; WHO, 2018). It is also currently
unknown as to how physical activity could be used to improve the screening
and diagnosis of OSA.
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1.2 Aim and objectives of this thesis
Aim:
To examine the role of physical activity in the diagnosis and treatment of
OSA 
Objectives: 
1. To critically examine published evidence syntheses on exercise as a
treatment for OSA 
2. To explore whether physical activity-related questions (similar to those
on existing OSA screening tools) are:
a) Associated with the severity of SDB
b) Can be used to improve the diagnostic performance of a current
OSA screening questionnaire
3. To undertake work in preparation for designing a protocol for a
feasibility randomised controlled trial (RCT) examining the benefits of
exercise for patients with OSA:
a) Examine the validity of a potential outcome measure for the trial
b) Explore OSA patients’ views regarding exercise and physical
activity
4. To develop a protocol for a feasibility RCT examining the benefits of
exercise for patients with OSA
3 
     
 
        
      
          
        
           
         
           
         
        
       
        
           
       
       
          
      
 
1.3 Structure of this thesis
This thesis consists of nine chapters. There is the introduction to the thesis 
(chapter one), a chapter about OSA (chapter two), six core chapters 
(chapters three, four, five, six, seven and eight) and the overall discussion
and conclusion (chapter nine). Two of the core chapters (chapters four and
six) relate to the screening and diagnosis of OSA, and four of the core
chapters (chapters three, five, seven and eight) relate to the treatment of
OSA. An overview of the studies, which have been conducted to meet the 
thesis aim and objectives, is provided in figure 1.1. The diagnostic pathway
consists of a cross-sectional study (chapter four), which leads into clinical
work (chapter six). The treatment pathway commences with a critical
overview of reviews (chapter three), followed by two chapters examining the
preparatory work that was undertaken to inform the design of a protocol for a
feasibility RCT (chapter five explores a potential outcome measure for this 
protocol, and chapter seven presents the patient and public involvement
(PPI) work that was conducted to inform the trial design). The protocol for the
feasibility RCT is presented in chapter eight.
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Diagnosis 
C4: The cross-sectional
association between walking
speed and obstructive sleep
apnoea in a multi-ethnic 
sample of older men and
women
C6: Are questions about
physical activity and walking
speed useful for the screening
of obstructive sleep apnoea in
weight-loss surgery patients?
Treatment
C3: A critical overview of reviews 
on the effects of exercise on the
severity of OSA
C5: Is flow-mediated dilation a
useful indicator of cardiovascular 
risk in patients with obstructive
sleep apnoea?
C7: Patient and public 
involvement: An exploration of
views regarding exercise and
physical activity amongst
weight-loss surgery patients with
obstructive sleep apnoea
C8: The benefits of exercise for 
obese people with obstructive
sleep apnoea who undergo
weight-loss surgery: A protocol
for a feasibility trial
Figure 1.1: The structure of this thesis (C = Chapter)
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Chapter Two: Obstructive Sleep Apnoea (OSA)
2.1 What is OSA?
2.1.1 Overview of OSA
Obstructed breathing encompasses a continuous spectrum of severity
ranging from loud snoring to physician-diagnosed severe OSA (Habib and
Phillips, 2007). OSA is one of the most serious sleep-related breathing
disorders and is characterised by multiple losses of airway patency during
sleep, resulting in partial (hypopnoea) and/or full (apnoea) airway obstruction
(Habib and Phillips, 2007; Aron et al., 2009) (Figure 2.1). The severity of
OSA is classified from mild to severe using the apnoea-hypopnoea index 
(AHI), which is the average number of apnoea (airflow is blocked for " 10 
seconds) and hypopnoea (airflow reduction of > 50% for ! 10 seconds) 
episodes per hour during sleep (Danjoux and Habgood, 2016; NHS, 2016) 
(Table 2.1). When accompanied by excessive daytime sleepiness, OSA is
called OSA syndrome (OSAS) (Danjoux and Habgood, 2016).
Figure 2.1: Partial and full airway obstruction (Obtained from Somers et al.,
2008)
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Table 2.1: Severity classification of OSA using the apnoea-hypopnoea index 
(AHI) (NHS, 2016)
OSA severity
classification
AHI
(Average number of apnoeas/hypopnoeas per hour of
sleep)
Mild 5 to 14
Moderate 15 to 30
Severe > 30
The prevalence of OSA in the general adult population is reported to be
between three and 17%, with men and older individuals bearing a greater 
risk for the disorder (Punjabi, 2008; Peppard et al., 2013). Much higher 
prevalence rates of between 50 and 70% have been reported in severely
obese populations (Riad and Chung, 2013; Chung, Abdullah and Liao,
2016). However, as stated in chapter one, reports suggest that a substantial
number of people with OSA, even those with obesity, remain formally
undiagnosed (Rejon-Parrilla, Garau and Sussex, 2014; Chung, Abdullah and
Liao, 2016).
Symptoms of the disorder include loud snoring, witnessed breathing pauses 
during sleep and excessive daytime sleepiness (Punjabi, 2008). Factors that
increase the risk of OSA include obesity, large neck size (> 40cm), male
gender, advancing age, craniofacial abnormalities (e.g. micrognathia,
acromegaly), enlarged tonsils and behaviours such as cigarette smoking and
alcohol use (Punjabi, 2008; Danjoux and Habgood, 2016).
2.1.2 Anatomy and pathophysiology of OSA
The upper airway can be divided into four anatomical subsections; the 
nasopharynx, the velopharynx (or retropalatal oropharynx, located between
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the hard palate and the soft palate), the oropharynx and the hypopharynx
(Ayappa and Rapoport, 2003; Fogel, Malhotra and White, 2004) (Figure 2.2).
The pharyngeal airway is a complex structure, which gives rise to our ability
for speech and vital functions such as respiration and swallowing (Fogel,
Malhotra and White, 2004). The pharynx has evolved to accommodate these
competing functions by sacrificing rigid support of the hyoid bone, a central
anchoring point for the tongue muscles (Ramar and Guilleminault, 2007).
Therefore, the upper airway is susceptible to collapse and relies largely on 
muscle activity to maintain airway patency (collapse usually occurs in the 
velopharynx or oropharynx or both) (Ayappa and Rapoport, 2003; Fogel,
Malhotra and White, 2004; Ramar and Guilleminault, 2007). The size of the
upper airway depends on the balance between forces that would collapse
the airway such as negative intraluminal pressure and increased tissue
(extraluminal) pressure, and forces that maintain airway patency (e.g. 
contraction of the genioglossus, a pharyngeal dilator muscle) (Fogel,
Malhotra and White, 2004).
Figure 2.2: Anatomy of the upper airway (Obtained from Fogel, Malhotra
and White, 2004)
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A number of theories have been proposed to explain the pathogenesis of
OSA, and it is thought that different factors contribute to the development
and severity of the disorder in different individuals (Nguyen, Yim and
Malhotra, 2007). However, the predominant theory of pathogenesis pertains 
to an anatomically small or more collapsible airway (e.g. due to increased fat
deposition around the airway) in combination with a sleep-induced fall in
upper airway muscle activity (Fogel, Malhotra and White, 2004; Danjoux and
Habgood, 2016). It is believed that increased activity of the upper airway
dilator muscles during wakefulness compensates for any predisposition to
airway collapse (Nguyen, Yim and Malhotra, 2007). However, these
neuromuscular compensatory mechanisms are lost during sleep and leave
certain individuals susceptible to apnoeic events (Danjoux and Habgood,
2016). Arousal from sleep is needed to restore airway patency (resumption
of breathing occurs with arousals secondary to an increase in oropharyngeal
dilator muscle tone) (Fogel, Malhotra and White, 2004; Danjoux and
Habgood, 2016). The consequence of this repetitive cycle and associated
hypoxemia and hypercapnia is a highly disrupted sleep period, which can be
detrimental to an individual’s health and daily functioning (Fogel, Malhotra
and White, 2004; Somers et al., 2008).
2.2 Potential consequences of OSA
The recurrent apnoeas/hypopnoeas characteristic of OSA lead to repetitive
episodes of intermittent hypoxemia, intrathoracic pressure changes and
arousals, which can activate a number of harmful disease mechanisms (e.g.
oxidative stress, sympathetic activation, systemic inflammation, metabolic 
dysfunction, endothelial dysfunction) (Somers et al., 2008; Dewan, Nieto and 
Somers, 2015) (Figure 2.3). It is perhaps not surprising to learn that OSA is
linked to serious health conditions (Rejon-Parrilla, Garau and Sussex, 2014).
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Figure 2.3: Potential pathophysiological components of OSA, activation of
disease mechanisms and development of cardiovascular disease (CV = 
cardiovascular) (Obtained from Somers et al., 2008)
In particular, there is evidence to suggest a strong association between OSA 
and vascular diseases (Budhiraja and Quan, 2007; Yeboah et al., 2011; 
Yacoub et al., 2017; Ryan, 2018; Tietjens et al., 2019), and reports indicate a 
prevalence of OSA between 30 and 60% in patients with hypertension, heart
disease and stroke (Lattimore, Celermajer and Wilcox, 2003). Moreover,
Redline et al., (2010) reported that moderate to severe levels of OSA were
associated with an approximately three-fold increased risk of ischemic stroke
in men in The Sleep Heart Health Study. In a meta-analysis of prospective
cohort studies examining the association of OSA with the risk of vascular 
outcomes and mortality, Xie et al., (2017) reported that moderate and severe
OSA were associated with significantly increased risks of major adverse
cardiac events and coronary heart disease. These latter authors also
reported that this relationship might differ by sex (Xie et al., 2017).
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The substantial evidence base linking SDB and vascular problems has led to
the inclusion of an item for hypertension being included on a well-recognised
OSA screening tool (the STOP-Bang questionnaire) (Chung, Abdullah and
Liao, 2016) and also brought to light the importance of considering OSA in
certain vascular disorders such as resistant hypertension (Tietjens et al.,
2019). Although work is needed to further investigate sex differences and
confirm and establish causality, the research certainly highlights the
importance of early diagnosis and treatment in order to reduce the damaging
physiological effects of OSA on the vascular system (Budhiraja and Quan,
2007; Tietjens et al., 2019). It is also evident from the research that any
strategy for treating OSA should include outcomes pertaining to these
vascular consequences. One such outcome could be the percentage flow-
mediated dilation of the brachial artery (FMD%), which is suggested to be an
early indicator of cardiovascular disease that is reduced in people with OSA 
(Ali et al., 2014; Hoyos et al., 2015).
In addition to compromising physical health, OSA can also impact upon an
individual’s cognitive function, leading to detrimental consequences for 
occupational and educational functioning and driving safety (Stranks and
Crowe, 2016). In a recent meta-analysis, Stranks and Crowe (2016) 
evaluated the effects of OSA on cognitive function (assessed using objective
neuropsychological measures). They reported that the greatest deficits were
found in the areas of psychomotor speed and executive function, with
memory functions, motor control, construction, attention and speed of
processing abilities affected to a lesser extent (Stranks and Crowe, 2016).
Excessive daytime sleepiness, a key symptom of OSAS, can further 
compound the ability to be effective and perform optimally in daily life (Johns, 
1993). Given the functionally limiting nature of the disorder, it is perhaps 
unsurprising that OSA has been associated with disturbances in mood and a 
poor health-related quality of life (Lacasse, Godbout and Series, 2002; Pichel
et al., 2004; Lee et al., 2016). These combined physical, psychological and
functional consequences of OSA can be devastating for the individual and
their family members and place strain on economic resources (Rejon-
Parrilla, Garau and Sussex, 2014).
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The societal and economic costs of OSA are substantial, and reports indicate
that OSA patients have a significantly increased risk of motor vehicle
crashes, consume extra health-care resources and may be more likely to
suffer from work-related injuries and work disability (including absenteeism) 
(Hirsch, Bansback and Ayas, 2015). It is particularly concerning to consider 
that these costs may escalate in the future given the current obesity problem
(Reed, Pengo and Steier, 2016). Further, as people are now living longer,
the OSA risk factor of age becomes a potential issue that could also
augment OSA-related economic costs (Rejon-Parrilla, Garau and Sussex,
2014). A current health economics report suggests that increasing diagnosis 
and treatment of the disorder could result in worthwhile economic gain for the
UK (e.g. by increasing workplace productivity and decreasing NHS spending
on road-traffic accidents and OSA-related comorbidities such as vascular 
diseases) (Rejon-Parrilla, Garau and Sussex, 2014). Therefore, it is clear 
that increasing the diagnosis and treatment of OSA is of paramount
importance to the nation and should be prioritised to a) improve the lives of
individual suffers and their families and b) reduce strain on already
compromised economic and health-care systems.
2.3 The diagnosis of OSA
Early diagnosis of disease is a key aim of current healthcare policy (Public 
Health England (PHE), 2016). Prompt diagnosis of disease can facilitate
treatment and potentially alter the course of a person’s life. The diagnostic 
process for OSA involves the use of screening tools (e.g. STOP-Bang
questionnaire) followed by more extensive testing in the person’s home (e.g.
overnight pulse oximetry) or a clinical environment (overnight
polysomnography or PSG) in conjunction with patient history and clinical
examination (Danjoux and Habgood, 2016). The following sections describe
these tools and tests in greater detail.
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2.3.1 Polysomnography
The ‘gold standard’ diagnostic test for OSA is supervised in-laboratory
overnight polysomnography (PSG) (Kapur et al., 2017). During PSG, multiple
physiologic signals are recorded and monitored while a person sleeps,
including brain waves (electroencephalogram, EEG), air flow from the nose
and mouth, chest and abdominal movements, heart rate and rhythm
(electrocardiogram, ECG) and blood oxygen levels (oximetry) (Division of
Sleep Medicine - Harvard Medical School, 2011) (Figure 2.4). Diagnosis and
severity of OSA (mild, moderate or severe) is made by a sleep specialist and 
is based on the history and severity of presenting symptoms and the AHI (as 
evaluated from the PSG) (National Institute for Health and Care Excellence
(NICE), 2008; Danjoux and Habgood, 2016) (Table 2.1). Yet, PSG is time
consuming, labour intensive, costly and may not always be available in the
immediate vicinity (Nagappa et al., 2015). Therefore, high quality home-
based sleep apnoea testing (e.g. overnight pulse oximetry measuring
parameters such as the oxygen desaturation index, ODI) is accepted as 
suitable in conjunction with the patient’s history and severity of presenting
symptoms for diagnosing OSA (NICE, 2008; Danjoux and Habgood, 2016;
Kapur et al., 2017). However, guidelines strongly indicate that complex (e.g.
where a patient has significant comorbidities) and unclear cases should still
be assessed with full PSG (Kapur et al., 2017).
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Figure 2.4: Polysomnogram highlighting the repeated breathing pauses 
(apnoeas) that happen in a person with OSA (EEG = electroencephalogram)
(Obtained from the Division of Sleep Medicine - Harvard Medical School,
2011)
2.3.2 Screening tools
Due to the extra time and resources needed for more in-depth OSA testing, a
number of screening tools (e.g. the STOP, STOP-Bang and Berlin
questionnaires) have been developed to help identify individuals who have a
greater risk of OSA and require further evaluation (Danjoux and Habgood,
2016). NB: The American Academy of Sleep Medicine (AASM) strongly
recommend that these self-report tools should not be used to make any final
OSA diagnoses and employed for screening purposes only (Kapur et al.,
2017).
The STOP (snoring, daytime tiredness, observed apnoeas and high blood 
pressure) and STOP-Bang (snoring, daytime tiredness, observed apnoeas,
high blood pressure - BMI, age, neck circumference and gender) 
questionnaires were developed and validated in surgical patients to facilitate
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the need for a quick, simple and concise screening tool for OSA (Chung et 
al., 2008; Chung et al., 2012; Chung et al., 2014; Chung, Abdullah and Liao, 
2016). The most widely used questionnaire, the STOP-Bang, consists of
eight ‘yes/no’ questions related to risk factors and indicators of OSA as 
abbreviated in the acronym (Chung, Abdullah and Liao, 2016) (Figure 2.5;
Appendix one). Each item is scored one point for a response of ‘yes’ and
zero points for a response of ‘no’, and a final score is calculated between 0-8 
points (Chung, Abdullah and Liao, 2016). For the general population, scores 
of 0-2 indicate a low risk of OSA, scores of 3-4 indicate an intermediate risk 
of OSA and scores of 5-8 indicate a high risk of OSA (patients can also be 
classified as higher risk of OSA if they answer ‘yes’ to two of the STOP items 
+ ‘yes’ to gender, age or neck circumference items) (Chung, Abdullah and
Liao, 2016). The STOP-Bang score is currently used clinically to stratify and
triage patients for extended testing (Danjoux and Habgood, 2016).
15 
  
 
 
        
 
 
 
 
Figure 2.5: The STOP-Bang questionnaire (Obtained from Chung et al.,
2014)
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Other OSA screening tools have also been developed, including the Berlin
Questionnaire (BQ), which was designed to screen for OSA in primary care
(Netzer et al., 1999). This questionnaire is comprised of three main 
categories pertaining to a) snoring and apnoeas during sleep, b) daytime
sleepiness and c) blood pressure and obesity (Pataka et al., 2014). A 
patient’s score is used to stratify them as being low or high risk of OSA 
(Pataka et al., 2014; Miller and Berger, 2016). The Epworth Sleepiness Scale
(ESS) is a validated questionnaire for assessing sleepiness in order to
identify individuals with excessive daytime sleepiness (Johns, 1991; Johns,
1993) (Figure 2.6; Appendix two). This self-administered questionnaire
consists of eight questions asking about an individual’s propensity to fall
asleep or doze in a number of routine daily activities, e.g. when watching TV 
or sitting and talking to someone (Johns, 1991). The chance of dozing (on a
scale from 0-3) is recorded for each of the eight questions, and a final score
is calculated out of 24 (Johns, 1993). A score of ! 12 on the ESS has been
highlighted as strongly suggestive of increased daytime somnolence
(Danjoux and Habgood, 2016).
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Figure 2.6: The Epworth Sleepiness Scale (Obtained from Johns, 1991)
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A number of studies have been conducted to compare the diagnostic 
performance of the STOP, STOP-Bang, BQ and the ESS (Cowan et al.,
2014; Pataka et al., 2014; Chiu et al., 2017). Cowan et al., (2014) found that
the STOP-Bang questionnaire had superior predictive performance
compared to the STOP and Berlin questionnaires at both cut-points AHI " 5
and AHI " 15 in a sleep clinic in Glasgow. Pataka et al., (2014) evaluated five
different questionnaires for assessing sleep apnoea syndrome in a single-
centre analysis in Greece. They found that the STOP-Bang questionnaire
had the highest sensitivity (97.6%), largest area under the receiver operating
characteristic curve (AUC) (0.73, 95% confidence interval (CI), 0.7-0.76) and
best odds ratio (5.9, 95% CI, 3.6-9.5), but the lowest specificity (12.7%) for 
AHI " 15. In a bivariate meta-analysis, Chiu et al., (2017) found that the
STOP-Bang questionnaire was a more accurate tool for detecting mild,
moderate and severe OSA (sensitivity: mild = 88%, moderate = 90% and 
severe = 93%) when compared against the STOP tool, BQ and ESS.
However, the STOP-Bang evidenced poor specificity results for all OSA 
severities (mild = 42%, moderate = 36% and severe = 35%) (Chiu et al.,
2017). These findings appear robust across the diverse studies reviewed and
indicate that although the STOP-Bang tool may perform well for OSA 
detection, its poor specificity is a limitation, which could lead to high false-
positive rates and unnecessary referrals to already struggling NHS services 
(Chung, Abdullah and Liao, 2016). Future work needs to examine how to
improve the specificity of this promising screening tool.
2.4 The treatment of OSA
The fundamental aims of OSA treatment are to reduce, and preferably
eliminate, nocturnal apnoeic events and decrease the severity of OSA 
symptoms (NICE, 2008; Spicuzza, Caruso and Maria, 2015). Appropriate
treatment can also alter the physiological and metabolic consequences of
OSA and potentially increase an individual’s lifespan (Deacon et al., 2016).
Several treatment options have been proposed to manage the disorder, 
including CPAP, mandibular advancement devices (MADs), upper airway
surgery, hypoglossal nerve stimulation, weight loss/lifestyle management
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strategies, positional therapies and pharmacological interventions (Deacon et 
al., 2016). Currently, the ‘gold standard’ treatment is CPAP for
moderate/severe OSA (with weight loss alongside for those who are
overweight/obese) and lifestyle advice/MADs for mild OSA (NICE, 2008;
Danjoux and Habgood, 2016).
2.4.1 CPAP, MADs and weight loss
CPAP uses positive pressure to splint the upper airway open during sleep
(NICE, 2008). The CPAP device consists of a unit that generates airflow,
which is directed to the airway via a mask worn at night (NICE, 2008). The 
pressurised air acts to splint the upper airway open and prevents it from
collapsing (Sutherland, Phillips and Cistulli, 2015). Different CPAP devices 
(e.g. fixed or auto-titrating CPAP) are available and need to be chosen and
fitted with a clinical specialist (NICE, 2008). Oral appliances are the leading
alternative to CPAP (Sutherland, Phillips and Cistulli, 2015). Oral appliances 
such as MADs reposition the tongue and/or lower jaw to increase the
dimensions of the airway lumen, reducing airway collapsibility (Phillips et al.,
2013).
CPAP has shown to be effective in treating OSA and can eliminate/reduce
obstructive events, improve quality of life and decrease daytime sleepiness 
(Phillips et al., 2013; Deacon et al., 2016; Sharples et al., 2016). The
research suggests that MADs are also effective in the treatment of OSA, yet
approximately 40% of patients using these devices still exhibit a clinically
elevated AHI (Philips et al., 2013; Deacon et al., 2016; Sharples et al., 2016).
A randomised crossover trial (Phillips et al., 2013), meta-analysis of
randomised controlled trials (RCTs) (Sharples et al., 2016) and a recent
network meta-analysis (NMA) (Iftikhar et al., 2017) all provided evidence to 
suggest that CPAP is superior to MADs for improving the AHI in adults with
OSA. However, these studies were predominantly on men with moderate to
severe OSA. Therefore, interpretations may not generalise to all OSA 
patients. On other outcomes, such as sleepiness and quality of life, CPAP 
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and MADs show similar improvements (Philips et al., 2013; Sutherland,
Phillips and Cistulli, 2015; Iftikhar et al., 2017).
Despite the superior performance of CPAP for OSA severity reduction,
adherence to the treatment is a major concern. Adherence rates remain
persistently low over 20 years of data reporting (consistent non-adherence
rates of between 30 and 40%) (Rotenberg, Murariu and Pang, 2016).
Common complaints influencing disuse have been highlighted as dry nose
and mouth, general discomfort and perceived negative social impact (NICE,
2008; Deacon et al., 2016). While MADs also have side effects (e.g. tooth
and jaw pain and hypersalivation) and are not suitable for all individuals, they
do have higher adherence rates, e.g. > 75% (Sutherland, Phillips and Cistulli,
2015; Deacon et al., 2016). Such poor CPAP compliance rates have even
brought into question whether CPAP should still be accepted as the ‘gold-
standard’ of treatment for OSA, as high efficacy but low compliance could 
ultimately undermine overall treatment effectiveness (Rotenberg, Murariu
and Pang, 2016; Basyuni, Barabas and Quinnell, 2018). Future research is 
needed to examine this issue further.
Weight loss treatments are commonly used in the management of OSA.
Increased tissue pressure due to fat deposition in the upper airway can
magnify the chance of pharyngeal collapse (Joosten, Hamilton and
Naughton, 2017). Further, greater fat deposition in the chest and abdominal
regions can affect lung volumes and impact negatively on the disorder 
(Joosten, Hamilton and Naughton, 2017). In a longitudinal study of weight
change and SDB, Peppard et al., (2000) found that a 10% weight gain
predicted an approximately 32% increase in AHI and a 10% weight loss 
predicted a 26% decrease in AHI. Moreover, a recent meta-analysis of RCTs
found that weight loss through lifestyle interventions (largely diet-focused) 
resulted in a reduction in weight (mean difference -13.76 kg, 95% CI, -19.21 
to -8.32) and OSA severity (mean difference -16.09 events/h, 95% CI, -25.64 
to -6.54) (Mitchell et al., 2014). However, the high heterogeneity in the
summary effect for AHI (I2 = 92.2%) and predominance of data from men in
the studies they analysed makes it difficult to draw firm conclusions from this 
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work that can be generalised to the wider OSA population (Mitchell et al.,
2014). In a current NMA examining the effect of different interventions (e.g.
CPAP, MADs) on OSA, Iftikhar et al., (2017) concluded that dietary weight
loss, although not negligible, was the least effective for reducing the AHI
(mean treatment effect -12.27 events/h, 95% CI, -18.79 to -5.75). The
research presented, despite limitations, does indicate that weight loss has a
role to play in OSA therapy. However, to concur with Joosten, Hamilton and
Naughton’s (2017) conclusions from their narrative overview on the impact of
weight loss for the management of OSA, weight loss may not be a cure for 
all sufferers and most likely is a beneficial adjunctive therapy, especially in
obesity-related moderate to severe OSA.
Drawing conclusions on OSA treatment, the most efficacious therapy option
is undoubtedly CPAP. However, poor adherence rates may offset its
beneficial effects. MADs are a promising choice, yet are not suitable for all
individuals and still leave residual OSA. Weight loss shows promise as an
adjunctive therapy, but is unlikely to lead to a cure, especially in more severe
forms of the disorder. Overall, while these treatment options are
encouraging, there is still a need to investigate different therapy modalities 
for this life-altering disorder.
2.5 Physical activity and OSA
It is widely accepted that physical activity is important for disease prevention
(WHO, 2018). Over the past decade, an emerging body of research has 
evolved to suggest that physical activity may have benefits for reducing the
severity and symptoms of OSA (Peppard and Young, 2004; Simpson et al.,
2015; da Silva et al., 2017; Kline et al., 2017). In their early work, Peppard
and Young (2004) measured the association between exercise and SDB in
participants enrolled in the Wisconsin Sleep Cohort Study (N = 1104) and
reported a statistically significant trend between decreasing mean AHI and
increasing hours of weekly exercise. Interestingly, the authors observed that
this association persisted even after accounting for measures of body
habitus (Peppard and Young, 2004). Encouragingly, more recent studies 
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have all evidenced results in-line with this research. Simpson et al., (2015) 
found that in comparison with moderate exercise, the high, low and nil
exercise groups in their case-control study had an odds ratio for moderate-
severe OSA of 0.6 (95% CI, 0.5-0.8), 1.6 (95% CI, 1.2-2.0) and 2.7 (95% CI,
1.9-3.7) respectively. Further, in a large population-based study (N = 5453),
da Silva et al., (2017) observed that exercise was significantly associated
with lower odds for moderate and severe OSA. Finally, Kline et al., (2017) 
examined the associations of sedentary time and moderate to vigorous-
intensity physical activity (MVPA) with SDB and polysomnographic sleep in
community-dwelling adults and concluded that high sedentary time and low
MVPA, and especially their combination, were associated with higher AHI
values. BMI was adjusted for in all three of these studies (Simpson et al.,
2015; da Silva et al., 2017; Kline et al., 2017).
As a whole, these intriguing findings certainly appear to support the proposal
that being less physically active independently increases the risk and
severity of OSA. Therefore, interventions that involve increasing physical
activity levels may provide a much-needed alternative treatment avenue for 
OSA patients. Although the results so far are promising, the predominant
cross-sectional nature of the research reviewed limits the ability to make any
definitive inferences about causality, and while PSG was used to assess 
sleep across all of the studies, physical activity was unanimously self-
reported. Self-reported and objectively assessed measures of MVPA and
sedentary time have shown to be only modestly correlated, so it is possible
that the data collected may not reflect participants’ ‘true’ activity levels (Kline
et al., 2017). So, before advancing further with the thesis it is important to
examine whether these results are supported by higher-level evidence in
RCTs. Consequently, chapter three presents a critical overview of reviews on
the effects of exercise on the severity of OSA. Before moving to this chapter,
the potential mechanisms explaining the effect of increased physical activity
on OSA will be discussed.
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2.5.1 Physical activity-related mechanisms and OSA
It is commonly assumed that increased physical activity leads to a reduction
in BMI (an important risk factor for OSA), which in turn reduces OSA severity
(Peppard and Young, 2004). However, the independent associations 
between increased physical activity and a reduced severity of OSA reported
in the studies reviewed indicate that there are other ‘activity-related’ or 
‘exercise-specific’ mechanisms accounting for these reductions. The most
discussed mechanism pertains to the nocturnal ‘rostral fluid shift’ (RFS) 
(Redolfi et al., 2009). The RFS hypothesis proposes that sedentary living can
lead to increased fluid accumulation in the legs during the daytime (reduced
activity of the skeletal-muscle pump), which shifts to the rostrum (towards the
head) when lying supine to sleep, increasing tissue pressure and the 
propensity for upper airway collapse (Redolfi et al., 2009; Kline et al., 2017) 
(Figure 2.7). Redolfi et al., (2009) tested the hypothesis that the AHI during
sleep would be related to the amount of fluid displaced from the legs 
overnight and that this in turn would be related to the time spent sitting the
previous day. In support of the RFS, these authors found that in 23 non-
obese healthy men, the overnight change in leg fluid volume was strongly
correlated with the AHI (r = -0.773, p<0.001), the change in neck 
circumference (r = -0.792, p< 0.001) and the time spent sitting (r = -0.588, p
= 0.003).
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Figure 2.7: The Rostral Fluid Shift: Daytime fluid accumulation in the lower-
extremities can shift to the neck and lungs in the supine sleeping position. Fluid
shifting to the neck may increase tissue pressure and cause the upper airway to
narrow, predisposing to OSA. Fluid shifting to the lungs may provoke 
hyperventilation, predisposing to central sleep apnoea (White and Bradley, 2013).
CSA, central sleep apnoea; PCO2, partial pressure of carbon dioxide; PCWP, 
pulmonary capillary wedge pressure; UA, upper airway; UA-XSA, upper airway
cross-sectional area. Figure obtained from White and Bradley (2013)
Higher-level evidence also supports the rostral shift mechanism (Redolfi et 
al., 2015; Mendelson et al., 2016). Mendelson et al., (2016) examined the
effects of a 4-week walking intervention (30 minutes walking five days per 
week) on the severity of SDB and the nocturnal RFS in a RCT of 34 adults 
with coronary artery disease (CAD) and moderate to severe SDB. These
authors found that the exercise group experienced a significantly greater 
decrease in the AHI compared to the control group, in association with a 
greater reduction in the overnight change in leg fluid volume (Mendelson et 
al., 2016). These reductions were also accompanied by an increase in the
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overnight change in upper-airway cross-sectional area in the exercise group
and occurred in the absence of any weight loss (Mendelson et al., 2016).
In a randomised crossover trial, Redolfi et al., (2015) found that a one-week 
walking intervention (two walking sessions per day, 45 minutes per session) 
resulted in an AHI reduction of 30% with a concomitant reduction in the
amount of fluid shifting from the legs to the neck overnight in eight sedentary
non-severely obese participants with moderate to severe OSA. However,
there are limitations to the research. The predominance of male participants 
and fact that one study assessed patients with CAD reduces the ability to
generalise from the results to females and other population groups. Also,
these latter two studies employed a walking intervention, which again
reduces the ability to generalise from the work to other modes of exercise.
Future research is needed to explore the effect of walking interventions on
the RFS in more diverse sample groups. As Kline (2016) suggests, this work 
should adopt walking protocols similar to Mendelson et al’s (2016), which
was more realistic and in-line with current exercise recommendations than
Redolfi et al’s (2015) regimen. Further work should also explore the effect of
different exercise modalities on the RFS (Kline, 2016).
It is uncertain at present as to whether reductions in AHI due to exercise are
an acute effect related soley to the RFS or whether exercise leads to
additional adaptations that contribute to AHI reduction alongside the RFS 
(Kline et al., 2016; Mendelson et al., 2016). While the research is certainly
promising regarding the RFS, there is also evidence to indicate that other 
mechanisms may be contributing to the reductions in OSA severity (Kline,
2016). Kline (2016) highlights that in one of his group’s research studies
examining the effects of a 12-week exercise intervention on OSA (Kline et 
al., 2011), post-intervention assessment of SDB severity was conducted
following a day where the participants had not exercised. Kline (2016) 
suggests that the 24% reduction in the AHI observed in this study is unlikely
to be attributable to the RFS if it is an acute training effect. Other 
mechanisms to explain these independent effects of exercise on SDB have
been proposed in the literature and include increased respiratory stability
26 
          
         
          
        
  
 
           
       
       
     
         
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
through more consolidated and deeper sleep, increased strength and fatigue
resistance of the upper airway dilators and decreased nasal resistance (Kline
et al., 2011; Kline, 2016). However, as Kline (2016, p. 24) states, “to date, 
these mechanisms have been inadequately tested and remain largely
speculative”.
To conclude, there is a growing body of evidence to support the RFS 
hypothesis, yet further research is needed using larger sample sizes and
more diverse populations and exercise modalities. Further research is also
needed to explore the other mechanisms discussed. This work could
improve understanding of the pathogenesis of OSA and help inform future
management of the disorder (Mirrakhimov, 2013).
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Chapter Three: A critical overview of reviews on the
effects of exercise on the severity of OSA
3.1 Introduction
Sleep is a fundamental requirement for optimal everyday functioning and is 
an essential component of human life (Kline et al., 2017). As discussed in
chapter two, disruptions to this vital behaviour can lead to negative
consequences for the individual, society and wider economy (Rotenberg,
Murariu and Pang, 2016). Poor adherence to the ‘gold-standard’ treatment
for OSA, namely CPAP, has led to increased interest in alternative methods 
of therapy to reduce daytime sleepiness, normalise sleep architecture and
improve numerous health-specific outcomes (Rotenberg, Murariu and Pang,
2016).
The possible utility of physical activity as a treatment for OSA has been
proposed in recent years after observing positive associations between being
more physically active and a reduced incidence of SDB (Peppard and
Young, 2004; Awad et al., 2012; Simpson et al., 2015; Kline et al., 2017).
Similar results in RCTs examining the effects of exercise on OSA have 
sparked interest among researchers, especially since OSA severity reduction
has occurred despite minimal/no weight loss (Kline et al., 2011; Sengul et al.,
2011). Encouragingly, the current evidence-base does appear to indicate
that there is an ‘exercise-specific’ pathway for improving OSA.
In order to synthesise this body of research, a number of reviews examining
the effects of exercise on OSA have been conducted over the past five years 
(Araghi et al., 2013; Iftikhar, Kline and Youngstedt, 2014; Aiello et al., 2016; 
Iftikhar et al., 2017). However, this increase in publications can lead to
“information overload” and make it more difficult for the end-user to access 
and process pertinent information that could be of benefit to clinical practice
(Pollock et al., 2016. p. 2). An approach adopted to address this issue is the
overview of reviews (overviews), which “integrate information from multiple
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related systematic reviews to provide a comprehensive synthesis of all SR
evidence related to a specific clinical question” in one user-friendly document
(Pollock et al., 2016. p. 2).
To date, no such overview of reviews has been undertaken with regards to
the effects of exercise on OSA in adults. An overview was deemed
necessary in the earlier stages of this thesis to a) identify and solidify the
most recent key findings/research needs within the field and b) examine the
consistency and robustness of the reviews that have been conducted to
date.
3.1.1 Aim
The aim of this chapter was to provide an overview of the latest systematic 
reviews and meta-analyses examining the effects of exercise on OSA in
adults.
3.1.2 Objectives of this Chapter
1. To provide a critical analysis of the published evidence syntheses on
exercise as a treatment for the symptoms of OSA 
2. Examine the consistency across, and quality of, the latest systematic 
reviews and meta-analyses regarding the effects of exercise on OSA 
3.2 Methods
This overview of reviews was registered with PROSPERO
(CRD42013006052) (Appendix three). Searches were conducted in August
2016 and updated in November 2017. The databases Scopus, CINAHL,
Ovid, Web of Science and the Cochrane Library (Cochrane Reviews) were
searched from 1980 to November 2017. The search was refined to look only
in the search field ‘title’ in each database. It was thought that because the
key search terms were such important descriptors of the work, they would be
in the ‘title’ of all relevant articles. The search strategy is provided in 
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appendix four. Search terms were designed to target reviews that met the
following specific inclusion criteria:
• Published review papers dedicated to studies on the specific 
population of adults (males and females !18 years old) diagnosed
with having OSA
• Reviews in which studies on the effects of exercise interventions on
OSA were considered (physically active exercise interventions and not
e.g. oropharyngeal exercises). Reviews were only included if they
stated the words ‘exercise/lifestyle intervention’ in their title.
• Reviews needed to have specifically included a meta-analysis on the
studies in which the effects of exercise on the AHI outcome
(measured on a continuous ratio interval measurement scale) pre-
and post- intervention were quantified.
• Be classified as a systematic review/meta-analysis (as stated in the
title)
• Reviews/meta-analyses of RCTs or non-RCTs were considered.
Reviews/meta-analyses were excluded from this overview if they:
• Predominantly focused on studies looking at the effects of weight
loss/diet on OSA
• Were a conference abstract
• Were not written in the English language
• Were reviews on diagnosis issues 
• Focused on surgical interventions for OSA
Two researchers (SS, GA) independently screened titles and abstracts for 
eligible reviews. SS and GA agreed upon and obtained full papers for eligible
articles. SS and GA independently assessed the eligible articles and
unanimously agreed on the final papers for inclusion in this overview. If had
been needed, any disagreements between the two reviewers would have
been resolved through discussion/contacting a third reviewer.
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Data for each review was extracted manually by one author (SS) and
collated in tabular format. Data extracted included the review aim, study
inclusion criteria for the review and, in particular, the meta-analysis results 
for AHI, ESS and BMI. The reviewers (GA, SS) met to discuss and review
the data that had been extracted by SS. A valid and reliable tool, the
AMSTAR (Appendix five), was used to assess the methodological quality of
each review (Shea et al., 2007; Shea et al., 2009). The AMSTAR consists of
11 criterion items, with each awarded a score of one if the specific criterion is 
met for that item (item answer = ‘yes’) and a score of zero if the criterion is 
not met (item answer = ‘no’, ‘not applicable’ or ‘can’t answer’) (Sharif et al.,
2013). An overall AMSTAR score was calculated for each paper and
categorised as high (8-11), medium (4-7) or low (0-3) (Sharif et al., 2013).
Two researchers (SS, GA) agreed on the AMSTAR score for each review.
No statistical analyses or additional meta-analysis were performed for the
present overview of reviews, but verity of individual trial data extraction in
each review was scrutinised. A critical analysis of the reviews was presented
using a narrative synthesis. All work in this chapter was conducted using
expert advice from a current paper by Pollock et al., (2017), ‘Selecting and
implementing overview methods: implications from five exemplar overviews’
and a paper by Smith et al., (2011), ‘Methodology in conducing a systematic 
review of systematic reviews of healthcare interventions’.
3.3 Results
3.3.1 Search Results
A total of 97 references were retrieved from the searches. Of these, 91 were
excluded by their title/abstract, as they did not meet the inclusion criteria. Six
papers were obtained for further assessment. Two papers were excluded as 
they focused predominantly on diet-based interventions. Four reviews 
(including meta-analyses) were included in the final cohort in the present
overview of reviews (Figure 3.1).
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Figure 3.1: Flow diagram for selection of reviews
3.3.2 Characteristics of included reviews
The characteristics of the reviews are detailed in table 3.1. The four reviews 
and meta-analyses included in this overview were published between 2013
and 2017 (Araghi et al., 2013; Iftikhar, Kline and Youngstedt, 2014; Aiello et 
al., 2016; Iftikhar et al., 2017). Three reviews were meta-analyses examining
both RCTs and non-RCTs (Araghi et al., 2013; Iftikhar, Kline and
Youngstedt, 2014; Aiello et al., 2016). The fourth paper conducted a
network-meta analysis (NMA) of RCTs (Iftikhar et al., 2017). The NMA 
technique allows for the comparison of multiple treatments “simultaneously in
a single analysis by combining direct and indirect evidence within a network
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of randomised controlled trials” (Rouse, Chaimani and Li, 2017. p. 103). This 
“powerful analytical tool” (Khalifah et al., 2018. p. 1) was employed by Iftikhar 
et al., (2017) to examine the comparative efficacy of CPAP, MADs, exercise
training (studied as a singular intervention) and dietary weight loss for the
management of sleep apnoea. In general, the reviews in this overview
reported data on studies of healthy males and females who were >40 years 
old with AHI >15 events/h and BMI >25 kg/m2. There was also a trend
towards exercise regimens that were aerobic (at least 30 minutes at a
moderate intensity), included resistance training and lasted on average 12
weeks (minimum training frequency of three times per week). Each review
included no more than eight small exercise studies (number of participants in
each exercise study ranged from nine to 25 for non-RCTs and 20 to 45 for 
RCTs). The minimum number of exercise studies included in a review was 
four. The AMSTAR scores for the four reviews ranged from 4/11 to 8/11.
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3.3.3 Exercise and AHI
All four reviews found that exercise reduced the severity of OSA as assessed
using the AHI (Table 3.2). Examining the RCT-only meta-analyses, Araghi et 
al., (2013) found that exercise-only training in adults with OSA decreased the
AHI (mean difference, 95% CI) by -4.66 events/h (-7.87, -1.44, I2 = 0%) and
Iftikhar, Kline and Youngstedt (2014) by -7.17 events/h (-12.48 to -1.87 I2 = 
0%). Iftikhar et al., (2017) also reported a significant reduction in the AHI
(mean treatment effect, 95% CI) of -17.23 events/h (-25.82 to -8.64) following
exercise training in their NMA. In meta-analyses including non-RCTs, the
reduction in AHI following training was (mean difference, 95% CI) -10.5 
events/h (-16.46, -4.53 I2 = 0%) (Araghi et al., 2013) and -6.27 events/h (-
8.54 to -3.99 I2 = 0%) (Iftikhar, Kline and Youngstedt, 2014). Comparing
exercise to other interventions for OSA, Iftikhar et al., (2017) reported that 
there was no significant difference between exercise and any of the other 
interventions, including CPAP for reducing the AHI (difference between
CPAP and exercise = -8.04 events/h, 95% CI -17.00 to 0.92). Exercise also
ranked as second out of all the treatments examined in terms of relative
efficacy for AHI reduction (P-Score = 0.63) (P-scores were used in this NMA 
to rank the treatments according to their effectiveness).
3.3.4 Exercise and ESS
The effects of exercise on daytime sleepiness (measured using the Epworth
Sleepiness Scale, ESS) were reported in three reviews (Table 3.2). Iftikhar,
Kline and Youngstedt (2014) reported reductions in the ESS score of -3.3 
points (-5.57 to -1.02 I2 = 82.52%) post exercise training. In their NMA,
Iftikhar et al., (2017) also found that exercise significantly reduced ESS 
scores (mean treatment effect, 95% CI) by -3.08 (95% CI -5.48 to -0.68).
These authors reported that this result placed exercise as first when 
comparing it against all other treatments investigated in terms of relative
efficacy for improvement in daytime sleepiness (P-Score = 0.75).
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3.3.5 Exercise and BMI
All four papers indicated that there were no significant changes in BMI
following exercise training (Table 3.2). In RCT-only meta-analyses, BMI
changes (mean difference, 95% CI) after training were reported as 1.05
kg/m2 (-1.71, 3.81, I2 = 0%) (Araghi et al., 2013), -0.57 kg/m2 (-1.34 to 2.49, I2 
= not reported) (Iftikhar, Kline and Youngstedt, 2014) and -0.61 kg/m2 (-2.31 
to 1.10, I2 = not reported) (Iftikhar et al., 2017). In meta-analyses including
non-RCTs, the changes in BMI (mean difference, 95% CI) were -0.49 kg/m2 
(-3.20, 2.22, I2 = 0%) (Araghi et al., 2013) and -1.37 kg/m2 (-2.81 to 0.07, I2 = 
76.92%) (Iftikhar, Kline and Youngstedt, 2014).
Aiello et al’s (2016) review (Table 3.2) was not included in the main text of
the results as there is uncertainty regarding whether the standardised mean
difference (SMD) or the unstandardised mean difference (USMD) has been
used as the summary statistic in their meta-analysis, which makes it difficult
to interpret the results. In their paper, Aiello et al., (2016) do report that
exercise training reduced the AHI (-0.536, 95% CI -0.865 to -0.206, I2 = 20%) 
and ESS scores (-1.246, 95% CI -2.397 to -0.0953, I2 = 86.95%?) without a
significant change in BMI (-0.0473, 95% CI -0.375 to 0.280, I2 = 0%).
3.4 Discussion
3.4.1 Exercise and AHI
There is a consistent message throughout the papers reviewed suggesting
that exercise significantly reduces the AHI. However, the size of effect is 
highly variable across the reviews, potentially due to the inclusion of different
studies within each analysis. AHI reductions increase from -4.66 events/h (-
7.87, -1.44) (Araghi et al., 2013) to -17.23 events/h (-25.82 to -8.64) (Iftikhar 
et al., 2017) in the RCT-only meta-analyses (Table 3.3). The variation in the
sizes of AHI reduction makes it difficult to determine how much exercise can
improve OSA severity, especially given the uncertainty in the estimates.
Nevertheless, there does appear to be a definite increasing trend towards
51 
           
        
       
        
 
      
 
 
   
 
  
     
  
 
 
 
  
 
     
   
 
 
 
          
       
         
          
           
           
       
         
          
        
        
             
         
         
          
          
values that could clinically improve a patient’s OSA e.g. a reduction of seven
events/h could change a patient’s OSA severity classification from moderate
(15-30 events/h) to mild (5-14 events/h) and possibly alter clinical
management of the disorder (Danjoux and Habgood, 2016).
Table 3.3: Reductions in AHI following exercise training for RCT-only 
analyses 
Review AHI reduction
(events/h)
95% CI
Araghi et al., (2013) -4.66
(Mean difference)
-7.87 to -1.44
Iftikhar, Kline and Youngstedt 
(2014)
-7.17
(Mean difference)
-12.48 to -1.87
Iftikhar et al., (2017) -17.23
(Mean treatment effect)
-25.82 to -8.64
In order to treat patients most effectively it is important to understand how
interventions for OSA compare against each other. An interesting finding
from the NMA was that there was no significant difference between exercise
and any of the other treatments for reducing the AHI, including CPAP, to
which exercise ranked in second place in terms of relative efficacy for AHI
reduction (difference of -8.04 events/h, 95% CI -17.00 to 0.92) (Table 3.2).
This particular result is encouraging given that CPAP is the ‘gold standard’
treatment for OSA (NICE, 2008). However, it must be noted that Iftikhar et 
al., (2017) found that in the estimates between ‘CPAP: Exercise: MADs’ and
‘CPAP: Exercise’ there were some “statistical conflicts in the network model” 
between direct and indirect estimates for analyses on AHI (Tonin et al., 2017. 
p. 4). They state that they could not investigate this inconsistency “due to the
frequentist methodology” used in the NMA and advise that the findings for 
these analyses are interpreted with caution (Iftikhar et al., 2017. p. 12).
Moreover, there were a relatively small number of participants in the exercise
training studies, which as the authors suggest may have contributed to the
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absence of statistical significance in the difference between exercise training
and the other interventions. These observations indicate that further research
is most definitely needed before conclusions can be made regarding how
exercise compares to CPAP for reducing OSA severity.
Comparisons of exercise to other interventions were also made in Araghi et 
al’s (2013) review (Table 3.4). In their meta-analysis, these authors 
compared the effect of exercise-only, diet-only and exercise/diet combined
interventions on the AHI. They concluded, “interventions that employed
physical activity alone were not successful in reducing AHI compared to
dietary approaches” and “a combination of diet and physical activity,
however, resulted in significant reductions in AHI” (Araghi et al., 2013. 
p.1556). This indicates that exercise-only interventions are not as good as 
dietary approaches for treating OSA. However, it is felt that the strength of
Araghi et al’s (2013) conclusions cannot be completely agreed with for a
number of reasons, namely, a) there is overlapping of confidence intervals,
indicating that the ‘true’ effect for the results could actually be similar 
between the approaches, b) there is high heterogeneity (I2 = 92% for RCTs 
and I2 = 94% for non-RCTs) in the diet-only analyses and c) only one study
was included in the RCT diet and exercise subgroup meta-analysis (it has 
been suggested that at least two, and potentially even a minimum of five
studies are needed for valid, powerful and transparent analyses in a meta-
analysis) (Valentine, Pigott and Rothstein, 2010; Jackson and Turner, 2017).
It is therefore not assumed that exercise is inferior to dietary approaches for 
reducing the AHI, especially as exercise-training studies ranked above
dietary-based interventions in Iftikhar et al’s (2017) NMA in terms of relative
efficacy for AHI reduction.
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Table 3.4: Results from Araghi et al’s (2013) meta-analysis examining the
effects of diet-only, exercise-only and diet and exercise combined
interventions on the AHI (events/h)
RCT analysis Mean difference (95% CI) Heterogeneity
Subgroup: Diet -4.42 (-14.44, 5.61) I2 = 92%
Subgroup: Exercise -4.66 (-7.87, -1.44) I2 = 0%
Subgroup: Diet + exercise -10.00 (-14.36, -5.64) N/A
Non-RCT analysis
Subgroup: Diet -15.00 (-25.56, -4.44) I2 = 94%
Subgroup: Exercise -10.50 (-16.46, -4.53) I2 = 0%
Subgroup: Diet + exercise -7.33 (-13.59, -1.07) I2 = 0%
3.4.2 Exercise and ESS 
The evidence reviewed suggests that exercise also significantly reduces 
daytime sleepiness as measured using the ESS. Again, the data are robust,
with all three papers examining this outcome finding a significant effect. The
sizes of ESS reduction were similar across the reviews, with Iftikhar, Kline
and Youngstedt (2014) reporting a reduction in ESS scores (mean
difference, 95% CI) of -3.3 (-5.57 to -1.02) and Iftikhar et al., (2017) a
reduction (mean treatment effect, 95% CI) of -3.08 (-5.48 to -0.68) (Table
3.2). Iftikhar et al’s (2017) NMA also placed exercise as first in terms of it’s 
relative efficacy for ESS improvement when compared to CPAP, MADs and
dietary weight loss (P-Score = 0.75). The evidence does strongly suggest
that exercise training could be an effective intervention for addressing a
highly debilitating effect of the disorder. Nonetheless, further research is 
needed to build on these preliminary yet promising results, as there are
issues that decrease the strength of the data. Firstly, there was high
heterogeneity for the ESS outcome in Iftikhar, Kline and Youngstedt’s (2014)
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meta-analysis (I2 = 82.52%) and these authors did not present a separate 
RCT-only analysis for this outcome. Additionally, the results from Aiello et 
al’s (2016) review, which again support the beneficial effect of exercise
training on the ESS, are unclear due to uncertainty regarding their meta-
analysis summary statistics.
3.4.3 Exercise, BMI and mechanisms of effect 
An interesting finding from this overview is that the improvements in OSA 
severity were not accompanied by significant changes in BMI. This 
observation held true across all papers. However, there is high heterogeneity
reported for the BMI outcome (I2 = 76.92%) in Iftikhar, Kline and
Youngstedt’s (2014) meta-analysis (Table 3.2). On further inspection of their 
forest plot, it would seem that data from one of the single group intervention
studies by Barnes et al., (2009) (which employed a very low calorie diet
alongside the exercise intervention and reported a much larger reduction in
BMI compared to the other studies presented in the forest plot) may be
responsible for this. Therefore the BMI findings are still considered to be
robust and provide good evidence to support the proposal that there are
‘exercise-specific’ mechanisms responsible for the positive effects of
exercise on OSA.
The reviews provided a number of these mechanistic explanations,
predominantly related to a) site-specific reductions in fat depositions in
structures surrounding the upper airway (increasing pharyngeal lumen size),
b) changes in muscle tone in the upper airway (potentially helping to 
maintain airway patency during sleep) and c) decreases in central fat tissue
independent of weight loss (abdominal adiposity in particular has a negative
effect on respiratory mechanics) (Araghi et al., 2013; Iftikhar, Kline and
Youngstedt, 2014; Iftikhar et al., 2017). It was also proposed that exercise
might lead to the normalisation of chemoreceptor sensitivity (which could
possibly improve breathing) and increase the time spent in slow-wave sleep,
a sleep stage associated with enhanced airway stability (Araghi et al., 2013; 
Iftikhar, kline and Youngstedt, 2014). Perhaps the most researched
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mechanism of effect proposed by the reviews pertains to the ‘rostral fluid
shift’ (the movement of fluid accumulated in the lower extremities during the
daytime to the rostral area when lying down to sleep at night), which has 
been implicated in upper airway collapse (see chapter two, section 2.5.1) 
(Redolfi et al., 2009; Iftikhar, Kline and Youngstedt, 2014). Further in-depth 
analysis of these intriguing mechanisms is most definitely needed to improve
understanding and treatment of the disorder.
3.4.4 Quality of reviews in this overview
The four reviews in this overview had AMSTAR scores of between 4/11 and
8/11, categorising them as medium to high quality given recommendations 
from the literature (high quality = 8-11, medium quality = 4-7 or low quality = 
0-3, Sharif et al., 2013) (Table 3.2). The lowest score was recorded for Aiello
et al’s (2016) review. Although the results do support the findings in the other 
reviews, there are concerns about the overall quality of evidence in this 
paper. Firstly, it is uncertain as to whether the authors have used the SMD or 
the unstandardised mean difference (USMD) as the summary statistic in their 
meta-analysis. In the abstract, methods and written text of the results 
section, Aiello et al., (2016. p.86) refer to the USMD, e.g. “data was pooled
using USMD due to the uniformity of scale and analysis”. However, in the
actual forest plots and discussion, reference is made to the SMD. It appears 
very much like the SMD has been used to summarise the data when
examining the actual numbers presented for the AHI reduction (-0.536, 95% 
CI -0.865 to -0.206), yet the results for the ESS outcome could be perceived
as either a SMD or an USMD (-1.246, 95% CI -2.397 to -0.0953). Further 
concerns are raised by the absence of plots/test values from the assessment
of publication bias and reporting errors e.g. inconsistent reporting of
heterogeneity for ESS analysis in certain parts of the paper and incorrect
information provided in ‘baseline characteristics of studies included in the
meta-analysis’ table. These ambiguities and errors decrease confidence in
the results of Aiello et al’s (2016) review. The other three reviews were of a
higher quality. Nonetheless, duplicate study screening was not conducted
following the initial search in Iftikhar et al’s (2017) NMA and they reported
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that publication bias assessment (which detected an apparent bias on visual
inspection of the funnel plot) was short of 16 studies and thus not
representative of all studies analysed. These increased chances for bias 
need to be considered when reflecting on the results.
3.4.5 Strengths and limitations of this overview
The work in this chapter was conducted in a systematic and comprehensive
manner, examining the latest research within the field of exercise and OSA.
Moreover, by adopting strict inclusion criteria, this overview of reviews was 
able to examine, as far as possible, the ‘exercise-specific’ effects of exercise
on OSA (excluding papers without an exercise-only meta-analysis for AHI
reduction). However, there are limitations to the work that need to be
discussed. Firstly, this overview does not examine the longer-term effects of
exercise on OSA as all four papers examined studies lasting no more than
24 weeks. There were also a number of quality-related issues across the
reviews as discussed in section 3.4.4 that may decrease the strength of the
evidence presented (e.g. reporting errors, publication bias). Further, the
quality of the primary studies across the reviews was not optimal and two of
the studies examined in the reviews included patients with heart failure
(Ueno et al., 2009; Servantes et al., 2012), which may reduce the ability to
generalise from some of the data. A number of the primary studies also
employed additional interventions alongside exercise training (e.g. breathing
exercises, CPAP). However, these additional interventions are not felt to
have affected the main conclusions, especially as a sensitivity analysis 
performed in Iftikhar, Kline and Youngstedt’s review (2014) (conducted by
systematically removing one study at a time from the analysis) indicated that
no one study changed the statistical significance of the overall results.
Finally, it is felt that the AMSTAR tool used to examine the methodological
quality of the 4 papers most likely did not provide a comprehensive enough
of an assessment for the final paper by Iftikhar et al., (2017), who applied a 
novel NMA approach to the research (Ge et al., 2016). The AMSTAR was 
also originally developed for use with reviews of RCTs only and in this 
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overview, three of the reviews included both RCTs and non-RCTs (Pieper et 
al., 2018).
3.5 Conclusions
This overview provides robust evidence to suggest that in adults with OSA 
exercise has a significant and potentially clinically meaningful effect on
reducing OSA severity and daytime sleepiness, independent of BMI.
3.5.1 Implications for practice
This overview indicates that exercise may be a very valuable treatment
option that compares well with current therapies for reducing the AHI.
Although the evidence presented does not allow for certainty regarding the
effect size, it does indicate that exercise training could be clinically effective.
As highlighted in the discussion, a reduction of seven events/h could change
a patient’s OSA severity classification from moderate (15-30 events/h) to
mild (5-14 events/h) and potentially modify clinical management of the
disorder (Danjoux and Habgood, 2016). Therefore, it is fair at present to
agree with Iftikhar et al’s (2017. p. 12) proposal, which suggests that
exercise training should be used as an “adjunctive therapy” option for 
reducing the AHI until future work identifies the ‘true’ magnitude of it’s effect
on the disorder.
Current evidence suggests that exercise training also has a beneficial effect
on daytime sleepiness. The size of the effect, a reduction in the ESS of three
points, is encouraging and may be clinically important as Patel et al., (2018) 
propose that the minimum clinically important improvement in the ESS lies 
between minus two and minus three points. Moreover, exercise training
could be more effective for treating daytime sleepiness than CPAP (CPAP 
has been shown to reduce the ESS by less than three points in recent
analyses (Bratton et al., 2015; Iftikhar et al., 2017)). Therefore, it is proposed
that patients and clinicians consider using exercise, which also has other 
important health benefits, for improving this outcome. However, it should be
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noted that there is still a need for further research to more confidently
support this recommendation.
3.5.2 Implications for research
It is evident from the results of this overview that exercise has a role to play
in the treatment of OSA. Further research is certainly warranted and it is 
suggested that researchers conduct high quality RCTs using larger and more
diverse sample groups and longer research timeframes to build on this 
promising evidence base. Researchers should particularly examine pertinent
issues such as, a) clarifying how large of an effect exercise has on reducing
the severity of OSA, and b) whether exercise is the most effective treatment
for addressing daytime sleepiness associated with the disorder.
59 
    
        
    
 
  
 
       
          
        
        
      
        
       
   
 
         
         
         
          
         
          
            
       
 
          
          
       
          
          
          
       
    
 
Chapter Four: The cross-sectional association between 
walking speed and obstructive sleep apnoea in a multi-ethnic 
sample of older men and women
4.1 Introduction
Sleep-disordered breathing is not uncommon in middle-to-old-age adults,
with current evidence indicating prevalence rates of more than 15% in this 
population group (Endeshaw et al., 2009; Marti-Soler et al., 2016). Screening
for the disorder is of paramount importance from both public health and
economic perspectives (Chung et al., 2013). As discussed in chapter two,
current screening is limited by costly and time-consuming procedures.
Consequently, there is interest in developing alternative diagnostic tools to
address these problems.
Although the potential physiological mechanisms have not yet been fully
elucidated, there is now a substantial body of research indicating that 
decreased physically activity is associated with worse severity of SDB
(Peppard and Young, 2004; Iftikhar et al., 2017; Kline et al., 2017). The body
of work analysed in chapter three is testament to this. Therefore, it is 
plausible to suggest that physical activity could provide an avenue for 
improving the screening of OSA. However, no screening tool has, to date,
included an item relating to physical activity.
One indicator of physical activity, which is also a robust indicator of general
frailty, has been reported to be walking speed (Stanaway et al., 2011).
Health-related thresholds for low and high walking speeds have recently
been formulated (Cesari et al., 2005). Therefore, it was hypothesised that a
simple ‘yes/no’ question, similar to those in existing screening tools, but
pertaining to reported walking speed, is associated with the severity of SDB. 
In this chapter, this hypothesis was tested with the large population-based
dataset from the Multi-Ethnic Study of Atherosclerosis (MESA).
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4.2 Methods
4.2.1 The MESA
The MESA is a large population-based study examining the early stages of
cardiovascular disease. The research objectives and design have been
published elsewhere (Bild et al., 2002). The MESA study was approved by
the local Institutional Review Boards of each participatory study site. The
local research ethics committee approved this cross-sectional analysis of the
MESA dataset. The study also meets the ethical standards of the
International Journal of Sports Medicine (Harriss and Atkinson, 2013).
4.2.2 The MESA participants
The MESA participants were 6814 men (47%) and women (53%) aged
between 45-84 years from six communities in the United States of America. 
Participants were from four different ethnic groups; white (39%), African-
American (28%), Hispanic (22%) and Chinese-American (12%). Data for the
MESA were collected during five examination points over a 12-year period.
Data for the present study were analysed from MESA exam two, undertaken
between 2002 and 2004.
4.2.3 SDB outcomes in the MESA
The outcomes relating to SDB were physician-diagnosed sleep apnoea, self-
reported apnoeic events, loud snoring heard behind a closed door and
daytime sleepiness. These outcomes were measured using a self-
administered sleep questionnaire, as detailed previously by Yeboah et al.,
(2011). Participants could choose from a list of answers for each question
with ‘don’t know’ provided as a response for apnoea and snoring items.
Guidelines from the American College of Physicians indicate that
polysomnography has, and continues to be used routinely for the diagnosis 
of OSA (Qaseem et al., 2014). Therefore, it is reasonable to assume that
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participants who answered ‘yes’ to the question relating to physician-
diagnosed sleep apnoea had undergone polysomnography as part of their 
diagnostic pathway (Ryan et al., 1995).
4.2.4 Walking speed in the MESA
An interviewer-administered physical activity questionnaire was also
completed. One question was: ‘When you walk outside of your home, what is 
your usual pace?’ Five response options were provided from ‘no walking at
all’ to ‘brisk or striding’. Self-reported walking speed has been shown to be a
good marker of measured walking speed in older adults in a recent large
population-based study (Syddall et al., 2015). To facilitate a simple ‘yes/no’
context in keeping with the traditional screening tools, a walking speed <0.89
m/s (or no reported walking) was classified as ‘slow’, with " 0.89 m/s 
classified as ‘average/ brisk’. The threshold used to define slow walking
speed was informed by Stanaway et al., (2011), who reported that walking
slower than 0.89 m/s was predictive of mortality. 
4.2.5 Additional MESA measurements
The self-reporting of the relevant variables in the MESA is in the tradition of
items on the current clinical STOP-Bang screening tool and facilitates a large
sample of participants for data analysis. The other study covariates included
age, sex and ethnicity. Each participant’s BMI and blood pressure were
measured during clinical evaluation (Bild et al., 2002).
4.2.6 Data reduction
All outcome variables were dichotomised in keeping with current screening
tools, such as the STOP-Bang. Responses to the ‘how loud is your snoring?’
question in MESA were recoded into whether snoring was ‘extremely loud-
can be heard through a closed door’ or not. Responses to ‘how often do you
feel excessively (overtly) sleepy during the day?’ were recoded into
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‘never/sometimes’ and ‘often/almost always’. Other items, including
physician-diagnosed sleep apnoea were already in a dichotomised format.
4.2.7 Data analysis
Data analysis was completed in the Statistical Package for the Social
Sciences (SPSS, version 21) and Stata (StatCorp, Texas, version 12.1).
Data were analysed with multivariable-adjusted binomial regression (with an
identity link function), providing risk differences and their confidence intervals 
(95% CI). Analyses were adjusted for age, sex and ethnicity. Multivariable-
adjusted Cox regression with a constant time-to-event variable (Barros and
Hirakata, 2003) was employed to derive prevalence risk ratios and 
associated 95% CIs for the six STOP-Bang items, as well as for the
additional slow-walking speed question. The minimum clinically important
effect was defined as a prevalence risk ratio of 1.11. This effect size implies 
that for every 10 people with sleep apnoea who have a slow walking speed
there are nine people with sleep apnoea who have a fast walking speed; that
is, one in 10 sleep apnoea cases is associated with a slow walking speed.
Thresholds for moderate, large, very large and extremely large effects were
deemed to be risk ratios of 1.43 (10/7), 2 (10/5), 3.3 (10/3) and 10 (10/1),
respectively.
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4.3 Results
Faster walkers were, on average, 3.5 years younger and 2.3 kg/m2 lower in
BMI than slower walkers. Faster walkers also comprised a lower proportion
of women and African-American participants and a higher proportion of white
participants (Table 4.1). The mean total number of medications was slightly
(0.4) higher in slow walkers than in average/brisk walkers.
Table 4.1: Characteristics of the slow and average/brisk walkers at
examination two in the MESA sample
Characteristic Slow
Walkers 
(N=1649)
Average/brisk
walkers
(N=4476)
95% CI for
difference
Age
(mean ± SD years) 66.2 ± 10.2 62.7 ± 9.9 2.9 to 4.1
BMI
(mean ± SD kg/m2) 30.0 ± 6.2 27.7 ± 5.0 2.0 to 2.6
Proportion women
(%) 59% 50% 6% to 12%
Total no. of 
medications
(mean ± SD)
5.4 ± 3.8 5.0 ± 3.7 0.2 to 0.6
Ethnicity
proportions (%)
White
African-American
Hispanic
Chinese-American
31%
38%
22%
9%
43%
23%
21%
13%
-9% to -15%
12% to 18%
-1% to 3%
-2% to -6%
* SD = standard deviation; CI = confidence interval
The prevalence of SDB outcomes in the dataset is presented in table 4.2.
The prevalence of physician diagnosed sleep apnoea, self-reported apnoeas 
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and loud snoring was higher in men compared with women (4.8 vs. 2.3 %, 
11.0 vs. 5.9 % and 23.6 vs. 16.9% respectively).
Table 4.2: The prevalence of SDB outcomes in men, women and the overall
MESA sample
SDB outcome Prevalence
in Men
Prevalence
in women
Overall 
prevalence 
N (%)
Physician-diagnosed sleep 
apnoea
140 / 2912 
(4.8%)
73 / 3213 
(2.3%)
213 / 6125 
(3.5%)
Self-reported apnoeas 240 / 2168 
(11.0%)
138 / 2335 
(5.9%)
378 / 4503 
(8.4%)
Loud snoring 347 / 1472 
(23.6%)
204 / 1207 
(16.9%)
551 / 2679 
(20.5%)
Daytime sleepiness 637 / 2950 
(21.6%)
740 / 3245 
(22.8%)
1377 / 6195 
(22.2%)
*The denominators vary for different outcomes depending on the number of ‘don’t know’ responses to
each STOP-Bang question
Slower walking speed was associated with an increased risk of all outcomes 
indicative of SDB, including physician-diagnosed sleep apnoea (Table 4.3).
These risk differences were adjusted for sex, age, and ethnic group. No
substantial interactions were found between walking speed, ethnic group and
sex. Risk differences were also similar when people who reported no walking
at all were removed from the analyses.
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Table 4.3: Multivariable-adjusted risk differences between slow and
average/brisk walkers for SDB. Multivariable risk differences were similar 
across ethnic groups; for men and women; when people who reported no
walking at all were removed from the analysis.
Study
outcome
Risk 
(‘slow’
walking
speed)
Risk 
(‘average/
brisk’ 
walking
speed)
Risk 
difference
95% CI
Diagnosed 
sleep apnoea
4.7% 3.2% 1.5% 0.4% to 2.5%
Self-reported
apnoeic 
events
10.7% 8.7% 2.0% 0.1% to 3.8%
Loud snoring 24.9% 20.1% 4.8% 1.2% to 8.3%
Daytime
sleepiness
26.4% 21.0% 5.4% 3.0% to 7.8%
* CI = confidence interval
In this chapter, it was also investigated whether slow-walking speed was an
independent risk factor for physician-diagnosed sleep apnoea compared with
other ‘yes/no’ type outcomes present in traditional OSA screening tools.
Questions relating to apnoea incidence and loud snoring were, as expected,
the strongest independent predictors of sleep apnoea (Table 4.4). Body
mass index was also an independent predictor of sleep apnoea (prevalence
risk ratio: 1.7). Nevertheless, the strength of the independent association of
slow-walking speed was approaching that of BMI. People who walked
relatively slowly had 1.5-times the risk of having sleep apnoea compared
with people who walked at a faster pace. This prevalence risk ratio was 
higher than the point estimates of the prevalence risk ratios for the screening
items of daytime sleepiness, sex and hypertension (Table 4.4).
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Table 4.4: Multivariable-adjusted prevalence risk ratios for the slow-walking
speed question and other ‘yes/no’ questions traditionally included on
screening tools such as the STOP-Bang tool.
STOP-Bang variable Prevalence
risk ratio
95% CI
Stopping breathing
during sleep
21.9 12.6 38.0
Loud snoring 2.1 1.5 3.1
BMI 1.7 1.2 2.5
Slow walking speed 1.5 1.0 2.1
Daytime sleepiness 1.3 1.0 1.8
Sex 1.3 0.8 1.9
High blood pressure 1.2 0.9 1.7
*CI = confidence interval
4.4 Discussion
In this chapter, the hypothesis that a simple ‘yes/no’ walking speed question
is associated with the severity of outcomes related to SDB was tested using
the MESA dataset. Slow-walking speed was independently associated with
an increased risk of SDB outcomes in this large population-based work.
Moreover, the simple walking speed question compared favourably with
other items present on existing screening tools for SDB, including sex,
daytime sleepiness and hypertension.
The prevalence of diagnosed sleep apnoea was greater in men (4.8%) than
in women (2.3%). Nevertheless, the multivariable-adjusted association
between sex and sleep apnoea was weak and not statistically significant
(Table 4.4), suggesting that other covariates, such as BMI, might be more
influential than sex per se. In this chapter, a substantial interaction between
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sex and slow-walking speed – sleep apnoea association was not found.
Endeshaw et al., (2009) analysed a population-level dataset (The
Cardiovascular Health Study) and reported an association between slow-
walking speed and SDB, but only in women. The authors reported that this 
sex-specific finding was unexpected, but postulated that the protective effect
of female hormones on airway collapse is lost after the menopause.
Endeshaw et al., (2009) obtained polysomnographic data from their 
participants while they slept at home, allowing the quantification of the rate of
apnoeas and hypopnoeas, in contrast to the self-report approach employed
in the present study. Nevertheless, the sample size in the current study was 
substantially larger than theirs (N = 6125 vs.1042), providing greater 
precision of estimation of effects in both sexes. In agreement with the
present findings, data from the Wisconsin Sleep Cohort Study indicated that
the association between habitual exercise and SDB was similar between
men and women (Peppard and Young, 2004). Further large population-
based research employing direct polysomnography, the ‘gold standard’
diagnostic test for OSA, is needed to clarify any sex differences in risk 
factors for SDB (Chung et al., 2013).
The prevalence of the SDB outcomes in the sample analysed, including
sleep apnoea, is consistent with those reported in other large studies (Young
et al., 1993; Enright et al., 1996; Pallesen et al., 2007). Sleep apnoea can
present itself as obstructive, central or mixed (obstructive/central) in nature.
Although the word ‘obstructive’ was not included in the sleep history
questionnaire in the MESA, the prevalence of central and mixed sleep
apnoea is much rarer in the general population than is OSA (White and
Bradley, 2013). Therefore, it is likely that the vast majority of cases of
diagnosed sleep apnoea in the present study are obstructive in nature.
The present study findings support the hypothesis that low levels of physical
activity increase the severity of SDB. One possible causal pathway for this 
hypothesis involves a bidirectional influence of obesity (Figure 4.1). A
habitual slow walking pace may, over time, contribute to weight gain, which
is an independent risk factor for SDB (Riad and Chung, 2013). Conversely, it
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is possible that more severe SDB mediates more daytime sleepiness and,
therefore, a decreased willingness or propensity for physical activity and a
faster walking pace (Chennaoui et al., 2015). This pathway is supported by
population-based research, which has found a statistically significant
association between sleepiness and a decreased walking speed (Stenholm 
et al., 2010). Because BMI is on this potential causal pathway, it was not
adjusted for in the primary analysis of risk differences.
Figure 4.1: The potential causal pathway(s) between physical activity and
severity of sleep-disordered breathing (Suri et al., 2015).
Nevertheless, in a follow-up analysis, slow-walking pace was compared
against other items, including BMI, on popular screening tools for SDB. Slow-
walking pace was found to be independently associated with the prevalence
of self-reported diagnosed sleep apnoea, with a point estimate prevalence
risk ratio that was slightly larger than those relating to sex, daytime
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sleepiness and hypertension. This finding was consistent even if the
participants who reported no walking at all were removed from the analysis.
In terms of clinical relevance, the point estimate for the prevalence risk ratio
for walking speed represents a moderate effect size, but the uncertainty
(quantified by the 95% CI) is such that the true population effect could be
trivial (< 1.11) to large (>2).
It is plausible that the causal pathway between walking speed and SDB 
involves ‘exercise-specific’ mechanisms, independent of BMI (Figure 4.1) 
(Peppard and Young, 2004; Iftikhar, Kline and Youngstedt, 2014). As 
previously explained in chapters two and three, a number of mechanisms 
mediating these changes have been postulated in the literature. At present, it
is believed that being physically active may decrease OSA severity by
increasing upper airway dilator muscle strength, reducing nasal resistance,
improving sleep architecture and preventing lower-extremity fluid
accumulation (via the skeletal-muscle pump, the ‘Rostral Fluid Shift’
hypothesis) (Kline et al., 2011; Mirrakhimov, 2013; Kline et al., 2017). All of
these exercise-mediated changes may help to maintain airway patency
during sleep and thus improve SDB (Kline et al., 2011). However, there is 
still a paucity of data to allow for any firm conclusions to be made regarding
the specifics of any of these potential mediating mechanisms, exercise and
OSA. 
In the MESA, only 4205 people answered the question relating to loudness 
of snoring, with 1526 participants reporting ‘don’t know’. The response rate
for self-reported perceptions of apnoea during sleep was also poor (Table
4.2). In contrast, 6125 (98%) of the 6232 participants assessed at exam two
were able to answer the walking speed question. Therefore, not only might
the association between walking speed and sleep apnoea be stronger than
other proposed risk factors, the question may be more easily-answered by
participants than other risk factors.
The large sample in the current study, together with the fact that statistically
significant associations were present, indicates acceptable statistical power.
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Nevertheless, a limitation is that this work was observational and cross-
sectional in nature, with risk of temporal bias. Therefore, one can only
speculate, as has been done above, about proposed causal mechanisms.
However, the finding that walking speed (an indicator of physical activity and
general frailty) is associated with less severe SDB, independent from BMI,
agrees with the evolving body of research, including a recent network meta-
analysis (NMA) of RCTs examining the effects of supervised exercise
interventions on sleep apnoea (chapter three) (Karlsen et al., 2017; Iftikhar et 
al., 2017).
4.5 Conclusion
This chapter has reported an independent association between self-reported
slow-walking speed and SDB outcomes in a large population-based study.
Prospective observational and experimental studies should follow to confirm
these encouraging findings. It is therefore proposed that a simple ‘yes/no’
question relating to slow-walking speed could improve the screening utility of
the STOP-Bang questionnaire.
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The results from the work conducted in this chapter were:
• Presented at the 19th Annual Congress of the European College of Sport
Science in Amsterdam, July 2014: Conference abstract ID: 265 (Oral
presentation - selected to present in the Young Investigators Award
category).
Suri, S., Batterham, A.M., Ells, L., Danjoux, G. and Atkinson, G.
Association between self-reported walking pace and indicators of sleep-
disordered breathing: A population-based investigation. 
• Written up and published in the International Journal of Sports Medicine
(Appendix six).
Suri, S.V., Batterham, A.M., Ells, L., Danjoux, G. and Atkinson, G. (2015) 
‘Cross-sectional association between walking pace and sleep-disordered
breathing’, International Journal of Sports Medicine, 36(10), pp. 843-847.
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Chapter Five: Is flow-mediated dilation a useful indicator of
cardiovascular risk in patients with obstructive sleep 
apnoea?
5.1 Introduction
OSA places great strain on the vascular system. Studies, including the large
population-based MESA, support a relationship between sleep apnoea and
an increased risk of cardiovascular events (Yeboah et al., 2011; Xie et al.,
2017). As discussed in chapter two, the causal pathway between sleep
apnoea and cardiovascular disease has been proposed to involve the
intermediary variables of elevated sympathetic activity, insulin resistance and
obesity (Cutler et al., 2002; Jean-Louis et al., 2008). Other abnormalities in
coagulation factors, platelet activation, inflammatory processes and/or 
endothelial function may also play a role in the pathogenesis of
cardiovascular disease in sleep apnoea (Jean-Louis et al., 2008; Somers et 
al., 2008).
The capacity of blood vessels to respond to physical and chemical stimuli in
the lumen is imperative to their functional role (Corretti et al., 2002). Ali et al.,
(2014) recently reviewed the utility of various early indicators of
cardiovascular events in OSA. One of these indicators was the percentage of
flow-mediated dilation (FMD%), a non-invasive measure indicative of
endothelial function in humans (Celermajer et al., 1992). Ali et al., (2014) 
reported that, in most studies, mean FMD% is lower for patients with OSA 
vs. healthy participants; an observation corroborated by Hoyos et al., (2015) 
in a recent review specifically on sleep apnoea and endothelial dysfunction.
The FMD% ratio index is calculated by dividing the change (in response to a
stimulus) in arterial diameter by the initial baseline diameter of the artery and
multiplying by 100 (Atkinson and Batterham, 2013a, 2013b). In order for 
FMD% to be a valid indicator of endothelial function (distinct from structure),
it is desirable that this ratio index scales consistently over the full range of
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measurements. Nevertheless, from the earliest studies onwards, FMD% has 
been reported to be negatively correlated, sometimes strongly, to initial
artery diameter (Celermajer et al., 1992; Atkinson and Batterham, 2013a).
Despite some attempts to explain this observation physiologically, there is 
evidence to suggest that it is due to the poor size-scaling characteristics of
the FMD% ratio index itself (Atkinson and Batterham, 2015). This 
confounding of FMD% is important because initial artery diameter has been
reported to predict the progression of subclinical atherosclerosis (Halcox et 
al., 2009) and cardiovascular events (Yeboah et al., 2009), as well as being
substantially higher in OSA patients (Namtvedt et al., 2013).
This potential obfuscation of arterial structure and function by the FMD%
index is seldom considered in the relevant literature. For example, less than
half of the thirteen studies on FMD% reviewed by Ali et al. (2014) actually
presented data for initial diameter. In only one of these studies (Namtvedt et 
al., 2013) was there an attempt to adjust FMD% for initial diameter.
Consequently, it has been questioned to what extent the reported lower 
FMD% in OSA is explained by the potentially higher initial artery diameter in
these patients (Atkinson, 2013).
Due to the observed lower FMD% highlighted in patients with OSA (Ali et al.,
2014), it is possible that this marker of endothelial functioning may have
clinical utility e.g. improve the diagnosis of OSA. The FMD% ratio index
could also be used as an outcome measure in future RCTs of the benefits of
exercise on OSA (including in the protocol proposed at the end of this 
thesis). However, before moving forward with FMD%, it is important to
address the potential inconsistent size-scaling of this ratio index as it could
lead to biased inferences in subsequent work (Lolli, Batterham and Atkinson,
2017).
Therefore, this chapter aimed to quantify any differences in initial brachial 
artery diameter and flow-mediated dilation (adjusted for initial artery
diameter) between people who did and did not report physician-diagnosed
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sleep apnoea in the dataset from the Multi-Ethnic Study of Atherosclerosis 
(MESA). As discussed in chapter four, this dataset has also recently been
analysed to explore other questions related to sleep apnoea, predominantly
because the dataset is very large, population-based and involved
comprehensive and standardised data collection methods (Yeboah et al.,
2011; Lin et al., 2015; Chew et al., 2016).
5.2 Methods
5.2.1 The MESA participants
As stated in chapter four, the MESA is a prospective cohort study on
subclinical cardiovascular disease. The overall MESA sample comprises 
6814 women and men, aged 45–84 years, recruited from six regions in the
United States of America. The full study design for the MESA has been
detailed by Bild et al., (2002). The MESA was approved by the local
Institutional Review Boards of each participatory study site. The local
research ethics committee approved this cross-sectional analysis of the
MESA dataset.
5.2.2 The sleep apnoea question in the MESA
During the second MESA examination, a self-administered sleep history
questionnaire was administered (Yeboah et al., 2011; Lin et al., 2015; Chew 
et al., 2016). A question was ‘Have you ever been told by a doctor that you
had sleep apnoea (a condition in which breathing stops briefly during
sleep)?’ Participants responses were either ‘yes’, ‘no’ or ‘don’t know’.
Among the 6814 MESA participants, 678 either did not participate in the
sleep history study or reported ‘don’t know’ to the sleep apnoea question and
were therefore excluded from analysis.
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5.2.3 The FMD% protocol in the MESA
Full details of the FMD% protocol in the MESA are described by Yeboah et 
al., (2009) and additional information regarding the scanning and reading
protocol is available at the MESA website (www.mesa-nhlbi.org). In brief,
brachial FMD% was measured non-invasively using ultrasound with
participants in a supine position after 15 minutes rest and a minimum of 6
hours fasting (Yeboah et al., 2009). Images of the right brachial artery (artery
imaged 5-9 cm above the antecubital fossa) were obtained using linear-array
multifrequency transducer technology operating at 9 MHz (GE Logiq 700
Device) (Yeboah et al., 2009). A standard blood pressure cuff was positioned
around the right arm (2 inches below the antecubital fossa) (Yeboah et al.,
2009). Once baseline images had been recorded, the cuff was inflated to 50
mm Hg above the participant’s systolic blood pressure for 5 minutes (Yeboah
et al., 2009). Digitised images of the right brachial artery were captured
continuously for 30 seconds before cuff inflation and for 2 minutes beginning
immediately before cuff deflation to document the vasodilator response, 
which is principally mediated by endothelium-derived nitric oxide (Corretti et 
al., 2002; Yeboah et al., 2009). Of the 6136 participants who recorded a
‘yes/no’ answer for the sleep apnoea question, 3354 completed the FMD%
protocol (1692 women and 1662 men). Of these participants, 104 (23 women
and 81 men) reported that a physician had diagnosed them with sleep
apnoea, giving an overall prevalence of 3.1% (1.4% in women and 4.9% in
men).
5.2.4 Data analysis
Data were analysed using FMD%, and an allometric approach (Atkinson and
Batterham, 2013a, 2013b; Atkinson et al., 2013). In this approach, initial and
peak diameters are logarithmically transformed (natural logarithm) and the
differences between these values are calculated. These differences in
diameter on the log scale are entered as the outcome in a general linear 
model with sleep apnoea diagnosis as the fixed factor and logarithmically-
transformed initial diameter as a covariate. The resulting adjusted estimates 
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of the flow-mediated response and associated 95% confidence intervals are
obtained after back-transformation. The allometric scaling exponent of ‘b’ is 
derived from the log-linear transformation of the simple allometric model 
based on the equation;
Peak diameter = a # initial diameterb 
The FMD% and allometric approaches were compared using unadjusted
models and models adjusted for sex, race and age. It is extremely important
not to covariate-adjust statistical models for variables that are on the causal
pathway between exposure and outcome (Schisterman, Cole and Platt,
2009). This issue has been highlighted by Levitzky and Redline (2009) 
specifically in the context of OSA and cardiovascular disease. These authors 
thought it crucial not to adjust for variables such as body mass, diabetes and
hypertension when the association between OSA and cardiovascular 
outcomes is being investigated because these variables are on the proposed
causal pathway (Jean-Louis et al., 2008). Therefore, these variables were
not entered as covariates in the statistical models used in this chapter.
Any ratio index like FMD% is naturally positively skewed even if the
numerator and denominator are normally distributed (Atkinson and
Batterham, 2013b). Therefore, the FMD% index was also examined following
natural logarithmic transformation. Descriptive sample statistics are mean ±
standard deviation (SD). The precision of inferential estimates is described 
by the 95% confidence limits.
5.3 Results
The correlation between FMD% and initial diameter was -0.43 (-0.57 to -
0.26, P<0.0005) in the sleep apnoea patients (Figure 5.1) and -0.42 (-0.45 to
-0.39, P<0.0005) in the undiagnosed participants. When FMD% was log-
transformed, these correlations reduced slightly to -0.36 (-0.52 to -0.18, 
P<0.0005) and -0.40 (-0.43 to -0.37, P=0.0005) respectively. The regression
slope for the FMD%-initial diameter relationship was -1.2 %/mm (95%CI: -0.7 
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to -1.7, P<0.0005) for sleep apnoea patients and -1.5 %/mm (95%CI: -1.4 to 
-1.6, P<0.0005) for undiagnosed participants.
Figure 5.1 The negative moderate correlation between initial artery diameter and
FMD% for the sleep apnoea patients in the MESA (Atkinson et al., 2016). This
figure shows that FMD% does not scale consistently over the full range of 
measurements.
The value of ‘b’ in the allometric model was 0.946 (0.924 to 0.969, P<0.0005) 
in the sleep apnoea patients and 0.942 (0.937 to 0.946, P<0.0005) in the
undiagnosed cohort. A percentage index is accurate for scaling a change in
size across the full measurement range only when ‘b’ = 1.000 (Atkinson et 
al., 2013).
In the unadjusted model, the sample mean ± SD estimate of FMD% was 
3.8±2.6% for sleep apnoea patients vs. 4.4±2.9% for undiagnosed
participants (95%CI for difference: 0.01 to 1.14%, P=0.045, table 5.1). In the
model adjusted for sex, ethnicity and age, mean ± SD estimates of FMD%
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remained unchanged (3.8±2.7 vs. 4.4±2.7%) and the estimate of the
difference between samples became more precise (95%CI: 0.07 to 1.12%,
P=0.028).
Table 5.1 Variables measured during the flow-mediated dilation protocol for people
in MESA who did, and did not, have physician-diagnosed sleep apnoea (estimates
not adjusted for race, sex and age).
Variable Sleep
apnoea 
(N=104)
Mean ± SD
Undiagnosed 
(N=3250)
Mean ±SD
95%CI for
difference
between
samples
Initial diameter (mm) 4.76 ± 0.89 4.31 ± 0.83 0.28 to 0.61
Peak diameter (mm) 4.93 ± 0.88 4.49 ± 0.82 0.28 to 0.60
Absolute diameter
change (mm)
0.17 ± 0.10 0.18 ± 0.11 -0.01 to 0.01
FMD% (%) 3.8 ± 2.6 4.4 ± 2.9 0.01 to 1.14
Dbase-adjusted FMD
(%)
4.4 ± 2.4 4.3 ± 2.4 -0.5 to 0.5
In the unadjusted model, mean initial diameter was 0.45 mm larger in the
sleep apnoea patients (95%CI: 0.28 to 0.61 mm, P<0.0005). This mean
difference was 0.19 mm (95%CI: 0.07 to 0.32, P=0.003) in the model
adjusted for sex, age and race. Use of the allometric approach to account for 
the confounding of initial diameter generally reduced the mean difference in
flow-mediated response between sleep apnoea patients and healthy people.
In the model adjusted only for initial artery diameter, the sample difference in
adjusted flow-mediated dilation was 0.02% (-0.49 to 0.50, P=0.92). In the
adjusted model, the difference between samples was 0.3% (95%CI: -0.1 to 
0.7, P=0.19), which is approximately half the mean difference quantified with
the FMD% index.
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5.4 Discussion 
In this chapter, the potential inconsistent size-scaling of the FMD% ratio
index was examined in order to appraise its value for further use within the
thesis. As previously discussed, it is vital that a ratio index scales 
consistently over the full range of measurements. In agreement with previous 
studies (Atkinson and Batterham 2013a, 2013b; Atkinson et al., 2013), the
moderate-to-strong negative correlation between FMD% and initial diameter 
indicates that this assumption is also violated for sleep apnoea patients in
the MESA (Figure 5.1). The analyses suggest that the inappropriate scaling
associated with FMD% leads to an exaggeration of the difference in flow-
mediated response between people diagnosed with sleep apnoea and
undiagnosed people in the MESA. Nevertheless, and in agreement with data
from some previous studies (e.g., Namtvedt et al., 2013), a clear mean
difference in resting brachial artery diameter was found between people with
and without sleep apnoea in the MESA.
Most of the past researchers on this topic have administered overnight sleep
studies to their participants. Consequently, previous studies have tended to
be relatively small and homogeneous in terms of participant sample (Jean-
Louis et al., 2008). A meta-analysis of the pooled mean difference in FMD%
between people with and without sleep apnoea has yet to be undertaken on
these past studies. However, Ali et al., (2014) reported that this mean
difference in FMD% tends to be 0.3-3.0%. The sample difference in FMD%
in the present study of 0.6% lies within this range. A pertinent point is that
statistical analyses have been covariate-adjusted for initial diameter in only
one of these previous studies (Namtvedt et al., 2013). This research group
reported a substantial influence of initial artery diameter on the FMD% index.
When the researchers adjusted for this confounding, the influence of a one-
unit change in the AHI on FMD% was reported to be -0.09 % (Namtvedt et 
al., 2013). Therefore, the difference in FMD% (adjusted for initial diameter) 
between an AHI of zero and twenty events/h can be estimated from this 
regression slope to be only 1.8%, which agrees with the clinically
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unimportant association found in the current analysis of the large population-
based MESA dataset.
This finding indicates that FMD% may not be appropriate to take forward in
the thesis and in other trials where future cardiovascular risk is the target
outcome, as it could lead to biased inferences and waste vital funding and
time (Lolli, Batterham and Atkinson, 2017). The evidence from the current
analysis of a large, population-based, multi-ethnic study, which involved
comprehensive and standardised data collection methods provides strong
support for this proposal. Nevertheless, there are limitations to the work,
which need to be discussed before a final conclusion can be made.
In terms of potential limitations, first, this study was based on an
observational cross-sectional design, which precludes the elucidation of the
temporal relationships between variables in the causal pathway. Although it
is thought most likely that sleep apnoea leads to endothelial dysfunction
(Jean-Louis et al., 2008), the reverse could also be true. Interventions 
designed to improve the symptoms of sleep apnoea such as CPAP have
been reported to improve FMD% in some studies (Hoyos et al., 2015), but
none of these previous researchers has, again, covariate-adjusted the
CPAP-mediated change in the flow-mediated response for any CPAP-
mediated change in initial arterial diameter.
A second limitation is that the diagnosis of sleep apnoea was based on self-
reported information, which may be influenced by recall bias. As discussed in
chapter four, the MESA recorded whether participants had ever been
physician-diagnosed with sleep apnoea. The word ‘obstructive’ was not
included in the question. However, the prevalence of the other apnoeas 
(central and mixed) is known to be much lower than that of OSA
(Morgenthaler et al., 2006). Therefore, it is likely that the vast majority of the
sleep apnoea patients in MESA had OSA. It is also likely that
polysomnography was used to diagnose sleep apnoea in the MESA 
participants who reported diagnosis, as guidelines from the American
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College of Physicians indicate that polysomnography has, and continues to
be used routinely in the clinical pathway for OSA (Qaseem et al., 2014).
5.5 Conclusion
In conclusion, the sex, race and age-adjusted mean FMD% of the MESA 
participants who reported physician-diagnosed sleep apnoea was 0.6%
lower than those participants who did not report such a diagnosis. This mean
difference was 0.3% and not statistically significant when the confounding
influence of initial artery diameter was allometrically-adjusted for. Therefore,
the MESA participants who reported physician-diagnosed sleep apnoea do
not demonstrate a clinically important reduction in flow-mediated dilation. 
The FMD% ratio index is therefore not carried forward for further exploration
in the thesis with regards to the treatment efficacy of exercise on OSA.
The results from the work conducted in this chapter were written up and
published in the Journal of Hypertension (Appendix seven).
Atkinson, G., Danjoux, G., Ells, L., Suri, S. and Batterham, A.M. (2016) ‘Brachial
artery diameter, but not flow-mediated dilation, is associated with sleep apnoea in
the Multiethnic Study of Atherosclerosis’, Journal of Hypertension, 34 (3), pp. 410-
413.
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Chapter Six: Are questions about physical activity and
walking speed useful for the screening of obstructive sleep
apnoea in weight-loss surgery patients?
6.1 Introduction
The UK has one of the fastest growing obesity rates in the developed world
(Reed, Pengo and Steier, 2016). Obesity increases the risk of morbidity and
mortality and poses a great challenge to the NHS (McIntosh, Hunter and
Royce, 2016; Reed, Pengo and Steier, 2016). In 2016, it was reported that
26.2% of adults in England were obese (BMI ! 30 kg/m2) and 2.9% were
‘morbidly’ obese (BMI ! 40 kg/m2) (Parliament, House of Commons (HOC),
2018). Although the projections are uncertain, forecasting indicates that the
economic cost of the nation’s increasing prevalence of obesity to the health
service alone could reach £8.3 billion by 2025 (Parliament, HOC, 2018).
Bariatric surgery refers to a group of procedures (e.g. stomach stapling,
gastric bypasses), which are used to facilitate weight loss in people with a
BMI above 40 kg/m2 or a BMI of 35-40 kg/m2 with other comorbidities such
as heart disease (NHS Digital, 2018). In 2015/16, bariatric surgeries to treat
obesity were performed most commonly in the North East of England
(Parliament, HOC, 2018). Such major surgery is not without risks, particularly
if an individual also has OSA, as this increases the risk of postoperative
respiratory problems, intensive care unit (ICU) admission and can prolong
the length of hospital stay (Chung et al., 2013; Riad and Chung, 2013; 
Chung, Abdullah and Liao, 2016).
Obesity is a known risk factor for OSA, with prevalence rates of the disorder 
reported in excess of 50% in bariatric populations (de Raaff, de Vries and
van Wagensveld, 2018). Pre-operative screening for OSA is essential to
optimise this groups’ perioperative management and enhance patient safety
across the surgical pathway. In order to risk stratify patients for more
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extensive diagnostic testing, the STOP-Bang questionnaire (chapter two, 
section 2.3.2; Appendix one) is recommended (Nagappa et al., 2017b).
Although the STOP-Bang is a concise and easy-to-use screening tool, there
are still concerns about low specificity leading to high false-positive rates,
which may ultimately impact negatively on limited NHS resources (Chung et 
al., 2013; Chung, Abdullah and Liao, 2016). Alternative scoring models and
the addition of further questionnaire items are increasingly being researched
in order to improve the diagnostic performance of the STOP-Bang tool
(Chung et al., 2013; Chung et al., 2014; Nahapetian et al., 2016; Sangkum et 
al., 2017).
The evolving body of literature supporting an association between physical
activity and the severity of OSA may provide a platform for improving the
STOP-Bang’s diagnostic utility (Iftikhar, Kline and Youngstedt, 2014; Iftikhar 
et al., 2017). This proposal is supported by the work conducted in chapter 
four, which examined data from the large population-based MESA. In this 
chapter, it was observed that a slower walking speed (an indicator of frailty) 
was associated with a greater prevalence of SDB, independently from other 
common screening factors (Suri et al., 2015). The point estimate prevalence
risk ratio for slow-walking speed was slightly larger than those found for 
several established STOP-Bang items, including sex, hypertension and
daytime sleepiness (Suri et al., 2015). While these observational data are
promising, further research is needed to provide stronger evidence to help
guide clinical practice. This is especially important for weight-loss surgery
candidates because the BMI item of > 35 kg/m2 on the STOP-Bang tool is 
essentially redundant – it is predicted that almost all these patients will
answer ‘yes’ to this question.
Therefore, in this chapter, the aim was to explore whether the addition of one
of two simple and easily reported questions relating to physical activity and
everyday walking speed could improve the diagnostic utility of the STOP-
Bang tool in weight-loss surgery candidates.
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6.2 Methods
This component of the thesis was conducted as part of a service evaluation
at James Cook University Hospital (JCUH), Middlesbrough, in collaboration
with Teesside University. The Research and Development team within South
Tees Hospitals NHS Foundation Trust (STHNHSFT) and the School of
Health and Social Care Research Governance and Ethics Committee at
Teesside University approved the evaluation (Appendices eight and nine). All
data was collected between February 2015 and June 2016.
Patients who meet strict criteria can be referred by their general practitioner 
into the Bariatric and Specialist Weight Management Services (SWMS) at
JCUH for weight-loss surgery (patients must have a BMI > 40 kg/m2 or a BMI
of > 35 kg/m2 with other medical comorbidities, have tried but failed to lose
weight through other methods, have weight issues that affect quality of life
and health and be fully committed to working with the Bariatric and SWMS 
team). The Bariatric and SWMS team, which includes dieticians and
psychologists, provides comprehensive and multidisciplinary support to all
patients in this pathway, e.g. educational support about topics such as 
preoperative lifestyle changes and information about post surgery and follow
up appointments (NHS, 2019).
As part of the normal clinical pathway, all patients referred to bariatric and
SWMS clinics at JCUH completed the STOP-Bang screening tool located on
the referral form during their first clinical evaluation with a bariatric nurse
specialist (Appendix 10). At JCUH, a modified version of the original STOP-
Bang questionnaire is employed whereby scores from a validated
questionnaire for assessing daytime sleepiness (Epworth Sleepiness Scale, 
chapter two, section 2.3.2; Appendix two) replace the original STOP-Bang
item ‘Tired’ (Do you often feel tired, fatigued, or sleepy during the daytime?) 
(Johns, 1991; Johns, 1993). A score of " 12 on this scale is dichotomised 
into a ‘yes’ for the STOP-Bang tool.
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For the current project, patients were asked to complete two physical activity-
related questions, which were added to the referral form. These questions 
were designed to be in keeping with those already present on the STOP-
Bang questionnaire i.e. short, simple and requiring a ‘yes’ or ‘no’ response. 
One question examined the patient’s routine physical activity participation
and one question asked about the patient’s everyday walking speed.
Milton, Bull and Bauman (2011) have reviewed a number of single-item 
physical activity questions in the literature. However, it is felt that none of
these items were suitable for the question regarding the patient’s routine
physical activity participation in the current project. Firstly, a number of the
items reviewed by Milton, Bull and Bauman (2011) did not fit the criteria for 
the current work of needing a binary ‘yes/no’ response. It was felt that of the
questions that did fit the criteria of needing a ‘yes/no’ response, the majority
of these were too specific and not inclusive enough, e.g. they included
details on how long/how often the activity had to be or were too suggestive
regarding accepted modes of activity.
The remaining single-item question, “Do you currently participate in any 
regular activity or programme, either on your own or in a formal class,
designed to improve or maintain your physical fitness?”) was very similar to
what was needed for the current project (Milton, Bull and Bauman, 2011. p.
204). However, the wording in this question was deemed unsuitable for the
current work because it was thought that the word “currently” might not have 
captured what the person did routinely and the phrase “in a formal class” was 
too restrictive regarding how exercise with others had to be carried out
(Milton, Bull and Bauman, 2011. p. 204).
For these reasons, a new question was designed for this project, ‘Do you
routinely participate in any physical activity or exercise (either on your own or 
with others) to improve or maintain your physical fitness?’. The second
question asked, ‘When walking during everyday activities, do you find that
you have to walk slower than other people?’ These additional questions were
not used in any clinical decision-making processes. The validity and reliability
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of these new questions have not been tested, but self-reported walking
speed has been shown to be strongly associated with measured walking
speed in adults (Syddall et al., 2015). Nonetheless, the validity and reliability
of the questions used in the current work would be fully examined before
being used in formal clinical practice.
Patients with a STOP-Bang score of " 4 (items scored using ‘yes’ = 1 and
‘no’ = 0) or patients with a STOP-Bang score of 3 with " 2 relevant
comorbidities (type 2 diabetes, cardiac disease e.g. angina/heart failure,
significant respiratory disease, e.g. COPD, significant renal disease – CKD "
4) or a BMI " 50 were triaged to the Sleep Medicine department at JCUH for 
overnight oximetry testing. A sleep consultant made a likely diagnosis of
OSA using the oximetry results. Weight-loss surgery patients whose oximetry
results suggested a likely diagnosis of OSA were seen in the sleep clinic at
JCUH for further clinical evaluation and treatment. NB: At the sleep clinic, full
PSG may be employed to confirm the diagnosis of OSA. However, full PSG
(which includes EEG) will only be used if deemed necessary (e.g. if the case
is complex/unclear) by the clinical specialist, as it is time and labour intensive
(Nagappa et al., 2015). Where possible, the clinical specialist will use the
oximetry data with the patient’s history and clinical examination to confirm
the OSA diagnosis during this appointment. As discussed in chapter two
(section 2.3.1), this practice is accepted in current clinical guidelines (NICE,
2008; Danjoux and Habgood, 2016; Kapur et al., 2017).
Data analysis was completed in the Statistical Package for the Social
Sciences (SPSS, version 24), Stata (Statcorp, Texas, version 14.2) and
MedCalc (Ostend, Belgium, version 18.11). All 122 patients responded ‘yes’
to the STOP-Bang item ‘BMI > 35 kg/m2’. Because there was, therefore, no
variance in this variable it was not included in the analyses (the model used
in analyses was the STOPANG model, with the abbreviation referring to all of
the conventional STOP-Bang items). The patients were allocated to one of
two groups based on their clinically judged likely diagnosis of OSA (likely
diagnosis OSA ‘yes’ and likely diagnosis OSA ‘no’). Demographic (mean,
SD) and prevalence (N, %) data for each STOPANG item, slow-walking
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speed and low physical activity levels were then computed separately for 
each group and differences between the two groups calculated (mean
difference, 95% CI or % difference, 95% CI). The differences in means for 
the demographic data were calculated using an independent samples t-test
in SPSS. All prevalence figures were obtained from frequency counts in
SPSS. A webpage called http://statpages.info was used to calculate the
confidence intervals for the % difference in prevalence figures. Area under 
the receiver operating characteristic curve (AUC, 95% CI) was calculated for 
the three STOPANG models (STOPANG, STOPANG + slow-walking speed
item (referred to as WS in the model) and STOPANG + low physical activity
level item (referred to as PA in the model)) and pairwise comparisons of
these AUCs (95% CI) were computed in MedCalc. Receiver operating
characteristic (ROC) curves for the three STOPANG models compared
against a reference line indicating 50% AUC were displayed graphically. The
best cut-points for ruling-in and ruling-out OSA, likelihood ratios and post-test
probabilities for the STOPANG + WS model were calculated in Stata.
6.3 Results
A total of 122 patients completed the STOP-Bang tool. Raw BMI data (height
and weight) was available for 121 patients. Ninety per cent of the 122 
patients had a STOP-Bang score of " 4. The quality control check for 
oximetry data was classified as ‘fail’ for two patients. However, a sensitivity
analysis conducted by removing these patients from the dataset and re-
running the analysis, did not change the overall results.
Of the 122 patients, 65 had a likely diagnosis of OSA (hereafter referred to
as OSA patients), giving a prevalence rate of 53.3%. The mean (SD) age
and BMI of OSA patients were 48.8(12.6) years and 50.0(7.5) kg/m2. OSA 
patients were significantly older, had higher BMIs and poorer oximetry
readings when compared to patients without a likely diagnosis of OSA 
(hereafter referred to as non-OSA patients) (Table 6.1).
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Table 6.1: Demographic data and prevalence of each STOPANG item, slow-
walking speed and low physical activity levels for patients with and without a
likely diagnosis of OSA.
Likely
diagnosis 
OSA
Yes 
65/122 
(53.3%) 
Likely
diagnosis 
OSA
No 
57/122 
(46.7%) 
Demographics: Mean
(SD)
Mean
(SD)
Mean Difference
(95% CI)
BMI 50.0
(7.5)
47.1 
(7.0)
-2.9 
(-5.6 to -0.3)
Age 48.8 
(12.6)
42.7 
(12.2)
-6.1 
(-10.5 to -1.6)
Oximetry (dips per hour) 23.6 
(21.3)
5.0 
(2.5)
-18.6
(-24.2 to -13.0)
Mean Saturation 92.9 
(2.4)
94.9
(1.8)
2.0 
(1.2 to 2.7)
RDI 41.3 
(21.4)
31.1 
(17.0)
-10.2 
(-17.2 to -3.2)
STOPANG+PA+WS: N
(%)
N
(%)
% Difference
(95% CI)
Reported snoring 64 
(98.5)
52 
(91.2)
-7.3%
(-10.4% to 1.9%)
Epworth " 12 29
(44.6)
25 
(43.9)
-0.7 %
(-19.6% to 18.3%)
Reported observed
apnoeas 
28 
(43.1)
27
(47.4)
4.3%
(-14.8% to 23.2%)
Hypertension 34 25 -8.4%
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(52.3) (43.9) (-27.2% to 10.9%)
Age (>50 years) 32
(49.2)
16 
(28.1)
-21.1%
(-38.2% to -2.2%)
Neck circumference
(> 40cm)
63 
(96.9)
45 
(78.9)
-18.0%
(-23.4% to -5.1%)
Gender (Male) 24
(36.9)
12
(21.1)
-15.8%
(-31.3% to 2.0%)
Low physical activity
level 
42 
(64.6)
38
(66.7)
2.1%
(-16.3% to 19.9%)
Slow-walking speed 54
(83.1)
35 
(61.4)
-21.7%
(-36.5% to -4.2%)
*BMI data N = 121; RDI = respiratory disturbance index; PA = low physical activity level; WS = slow-
walking speed; CI = confidence interval
OSA patients also had a higher prevalence of ‘yes’ responses to all
STOPANG items except ‘reported observed apnoeas’, which were higher in
the non-OSA patients. Only the STOPANG items for age and neck 
circumference were significantly different between the two groups (%
difference, 95% CI: age = -21.1%, -38.2 to -2.2, neck circumference = -
18.0%, -23.4 to -5.1). A slow-walking speed was reported significantly more
in OSA patients than non-OSA patients (% difference, 95% CI: 21.7%, 4.2 to 
36.5). A greater percentage of non-OSA patients than OSA patients reported
low physical activity levels (Table 6.1).
The STOPANG + WS model had the highest AUC (0.697, 95% CI 0.607 to 
0.777) (Table 6.2) and this was significantly greater than the AUC for the
other two models (difference in AUC, 95% CI: STOPANG vs. STOPANG + 
WS model = 0.0547, 0.0184 to 0.0909, STOPANG + WS vs. STOPANG + 
PA model = 0.0727, 0.0219 to 0.124) (Table 6.3; Figure 6.1). The STOPANG
+ PA model had the lowest AUC (0.624, 95% CI 0.532 to 0.710) (Table 6.2).
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Table 6.2: ROC curve performance for the three STOPANG models
Model AUC 95% CI
STOPANG 0.642 0.550 to 0.727
STOPANG + WS 0.697 0.607 to 0.777
STOPANG + PA 0.624 0.532 to 0.710
*ROC = receiver operating characteristic curve; AUC = area under the ROC curve; WS = slow-walking
speed; PA = low physical activity level; CI = confidence interval
Table 6.3: Pairwise comparison of ROC curves for the three STOPANG
models
Model Difference
in AUC
95% CI
STOPANG v STOPANG + WS 0.0547 0.0184 to 0.0909
STOPANG v STOPANG + PA 0.0181 -0.0213 to 0.0575
STOPANG + WS v STOPANG + PA 0.0727 0.0219 to 0.124
*ROC = receiver operating characteristic curve; CI = confidence interval; WS = slow-walking speed;
PA = low physical activity level
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Figure 6.1: Receiver operating characteristic curves for the three STOPANG
models compared against a reference line indicating 50% AUC
(WS = slow-walking speed; PA = low physical activity level; AUC = area
under the ROC curve)
Examining the STOPANG + WS model, it was found that the best cut-
point for ruling-in OSA was a score of ! 6 (Table 6.4). The associated
post-test probability indicated that a patient with a STOPANG + WS score
! 6 would have a 79% chance of having OSA. The best cut-point for 
ruling-out OSA was a score of " 3 (Table 6.4). The associated post-test
probability indicated that a patient with a STOPANG + WS score " 3 
would have a 28% chance of having OSA.
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Table 6.4: Best cut-points for ruling-in and ruling-out OSA, likelihood ratios 
and post-test probabilities for the STOPANG + WS model
Ruling in + Likelihood ratio
(95% CI)
Post-test probability
(95% CI)
" 6 3.65 (1.6 to 8.3) 79% (62% to 89%)
Ruling out - Likelihood ratio
(95% CI)
Post-test probability
(95% CI)
$ 3 0.39 (0.2 to 0.8) 28% (17% to 44%)
6.4 Discussion
In this chapter, it was found that a question pertaining to slow-walking
speed significantly increased the STOPANG models screening
performance in weight-loss surgery patients (increasing the AUC from
0.64 to 0.70). The best cut-points for ruling-in and ruling-out OSA for the 
STOPANG + WS model were ! 6 and " 3 respectively.
The high prevalence of OSA (likely diagnosis OSA ‘yes’ = 53.3%) was in
keeping with the literature for this population group in which prevalence
rates of > 50% are frequently reported (Chung, Abdullah and Liao, 2016;
de Raaff, de Vries and van Wagensveld, 2018). As expected, OSA 
patients had a higher prevalence of ‘yes’ responses to most of the
STOPANG items compared to non-OSA patients (Table 6.1). However,
the STOPANG item pertaining to ‘reported observed apnoeas’ was higher 
in the non-OSA patients (Table 6.1). Nagappa et al., (2017a) suggest that
this question may not be captured accurately if a patient’s bed partner is 
not present. Difficulties in answering this screening question may explain
the current finding. This highlights the importance of using questions in
screening tools that can be easily and accurately answered by patients.
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Self-reported walking speed has been shown to be a good marker of
measured walking speed in older adults (Syddall et al., 2015) and is an
easily answered question with good response rates reported (Suri et al.,
2015). In this chapter, it was found that significantly more OSA patients 
than non-OSA patients reported a slow-walking speed (% difference, 95%
CI: 21.7%, 95% CI 4.2 to 36.5) (Table 6.1). The fact that the prevalence
difference for the walking speed item in this chapter was larger than those
observed for any of the STOPANG items is highly encouraging as it
suggests that slow-walking speed may be able to better differentiate
between people with and without OSA than current clinical screening
questions. This finding also concurs with the theme throughout the thesis 
so far, which consistently supports a relationship between being less 
active and an increased incidence of SDB (Peppard and Young, 2004;
Awad et al., 2012; Simpson et al., 2015; Suri et al., 2015; Kline et al.,
2017).
Promisingly, when the walking speed item was added to the STOPANG
model it improved the AUC from 0.64 to 0.70 (Table 6.2). This AUC was 
significantly greater than the AUCs for the other two screening methods 
(Table 6.3). Again, the data support the clinical utility of a walking speed
question and suggest that adding a walking speed item to current
screening protocols may help to increase identification of patients with
OSA prior to weight-loss surgery. This would allow for an appropriate care
programme to be initiated prior to surgery, potentially decreasing the risk 
of OSA-related complications during the perioperative period (Riad and
Chung, 2013). Identification of higher-risk patients during this time would 
also allow clinicians to institute additional measures to manage the
patient’s OSA during the perioperative period, such as planning for 
increased monitoring and being more cautious of medications used
during anaesthesia (OSA patients may have an increased sensitivity to
perioperative opioids and sedation) (Danjoux and Habgood, 2016). This 
would facilitate a safer and more efficient perioperative journey, beneficial
to the patient, their support team and the NHS. The clinical pathway for
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identifying OSA in weight-loss surgery patients at JCUH is provided in
figure 6.2.
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Although the size of the STOPANG + WS’s AUC was classified at the lower 
end of ‘fair’ using suggested interpretations from the literature (AUC: " 0.9 = 
excellent, " 0.8 = good, " 0.7 = fair and < 0.7 = poor) it is still considered to
have potential as a screening tool, especially as the 95% confidence interval
for the AUC (0.61 to 0.78) did not include the null-value (AUC = 0.5) 
(Youngstrom, 2014). Higher AUCs are desirable for clinical screening tests,
yet putting the current work into context, AUCs for clinical OSA screening
tools are often not in the categories of ‘good’ or ‘excellent’ using the
suggested thresholds stated above, with research on-going to improve their 
screening utility (Pataka et al., 2014). The STOP-Bang variants, which have
been researched in an attempt to improve its diagnostic performance by
adding more items e.g. serum bicarbonate level (Chung et al., 2013), an
‘apple-body type’ (Sangkum et al., 2017) or by changing the way the tool is 
scored (Nahapetian et al., 2016), have still only yielded AUCs " 0.8. For 
example, using a large dataset (N > 1500) from the Sleep Heart Health
Study, Nahapetian et al., (2016) examined whether using different methods 
for scoring the STOP-Bang (a ‘weighted model’ and a ‘continuous model’) 
would improve its performance. These authors found that the AUC for the
conventionally scored STOP-Bang, the ‘weighted model’ and the ‘continuous 
model’ were 0.71, 0.69 and 0.74 respectively (Nahapetian et al., 2016).
An advantage of the current STOPANG + WS model is that unlike these
aforementioned STOP-Bang models, it omits the original BMI item, which
has a threshold value of 35 kg/m2. As this item is usually positive for the
majority of bariatric patients, it is proposed that it is inappropriate for use in
this population group. Therefore, the new STOPANG + WS model is 
considered a more appropriate tool for use with these patients.
Given the promising results for the walking speed item, it was interesting
that a similar trend was not seen with the question regarding physical
activity levels (a slightly decreased prevalence of low-physical activity
levels was observed in the OSA patients compared to non-OSA patients 
and the addition of the physical activity item decreased the STOPANG’s 
ROC performance) (Tables 6.1 and 6.2 respectively). Self-reporting of
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physical activity levels has been identified as problematic in the literature
with incongruence between objectively measured and subjectively 
reported figures (Bond et al., 2010). This may explain the unexpected
findings for this variable and again emphasises the need to really
consider the items carefully (e.g. validity, ease of measurement) when
designing a screening tool in order to optimise it’s diagnostic utility.
After further examining the STOPANG + WS model it was found that the
best cut-point for ruling OSA in was a score of ! 6 (Table 6.4). The
associated likelihood ratio of 3.65 (95% CI 1.6 to 8.3) indicated that a
score of ! 6 increased the probability of disease to 79% (95% CI 62 to 89) 
(post-test probability) (Table 6.4). Although the likelihood ratio was not
substantial (based on guidelines from the literature a likelihood ratio > 10
= large), the model’s best ruling-in cut-point raised the post-test
probability sufficiently high enough to warrant further testing (Deeks and
Altman, 2004). The best cut-point for ruling OSA out was a STOPANG + 
WS score of " 3, which decreased the probability of OSA to 28% (95% CI
17 to 44) (post-test probability) (Table 6.4). However, this probability is 
still too high to rule-out disease with confidence, indicating an area of
performance where this model may need further work to optimise its
screening utility (Deeks and Altman, 2004).
Finally, before drawing conclusions, the strengths and limitations of the
current chapter must be discussed. Firstly, this work is highly novel. The
effect of a physical activity/walking speed-related question on the STOP-
Bang’s diagnostic performance has not been previously examined in the
literature. A second strength is that because there was no variance in the
STOP-Bang’s item for BMI in this patient group, it was excluded from the
analyses. Including BMI may have compromised the results, as all
patients were positive for this item. There are also limitations of this work 
to consider. The sample size was relatively small (N = 122), diagnosis of
OSA was only a likely diagnosis based on oximetry data (not full PSG) 
and the different severity levels of OSA were not analysed. 
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6.5 Conclusion
Building on the work conducted in chapter four, this chapter explored
whether the addition of one of two simple and easily reported questions 
relating to physical activity and everyday walking speed could improve the
diagnostic performance of a currently used screening tool for OSA (STOP-
Bang). The findings suggest that a slow-walking speed question has the
potential to improve the diagnostic utility of the STOPANG tool in weight-loss 
surgery patients. The new STOPANG + WS model, which omits the BMI
item, is also considered to be a more appropriate screening tool for OSA in
bariatric populations. Further work using full PSG and larger samples is
needed to build on these preliminary yet promising results.
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Chapter Seven: Patient and public involvement: An
exploration of views regarding exercise and physical activity
amongst weight-loss surgery patients with obstructive sleep
apnoea
7.1 Introduction
Weight-loss surgery patients with OSA are at an increased risk of
perioperative complications (e.g. cardiopulmonary complications), which may
require admission to high dependency or intensive care units, increase the
length of hospital stay and even result in mortality (Dawson, Singh and
Chung, 2016). In the current NICE guidelines, CPAP is recommended for all
patient groups diagnosed with OSA (NICE, 2008; Danjoux and Habgood,
2016). Patients newly diagnosed prior to surgery should be treated as per 
NICE guidance with CPAP commenced 8-12 weeks preoperatively to reduce
perioperative risks (NICE, 2008; Danjoux and Habgood, 2016). Although
weight-loss surgery patients may be informed of the importance of CPAP,
compliance is poor (Thomas et al., 2013; Luyster et al., 2016). Alternative
management strategies are needed to reduce patient risk and potential
economic costs that may result from OSA-related complications (Chung et 
al., 2013; Danjoux and Habgood, 2016).
As has been previously highlighted within the thesis, exercise can reduce the
severity of OSA, independent of any weight-loss that may also occur (Iftikhar,
Kline and Youngstedt, 2014; Suri et al., 2015; Iftikhar et al., 2017). Therefore,
exercise prior to weight-loss surgery may improve OSA severity and also
address the low levels of cardiorespiratory fitness reported in this patient
group, which in itself can increase perioperative risk (McCullough et al.,
2006; Carver et al., 2011; Tew et al., 2018). Emerging evidence also
suggests that weight loss alone may not cure OSA (Joosten, Hamilton and
Naughton, 2017). This further supports the need for alternative or adjunct
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therapies such as exercise, which also offers many additional physiological
and psychological benefits (Iftikhar, Kline and Youngstedt, 2014).
However, guidance for providing safe and effective exercise prior to elective
major surgery is limited and further trials are needed to build the evidence
base (Tew et al., 2018). Consequently, in chapter eight of this thesis, a
protocol for a feasibility RCT examining the benefits of exercise for obese
people with OSA who undergo weight-loss surgery is proposed.
It is important to involve the public in the research process to increase the
relevance, quality and impact of this trial as they can provide unique
perspectives that cannot be gained from the research team and clinicians 
alone (INVOLVE, 2012; Brett et al., 2014; National Institute for Health 
Research (NIHR), 2014; Pandya-Wood, Barron and Elliott, 2017). INVOLVE 
(2012, p. 6) define public involvement in research as “research being carried
out ‘with’ or ‘by’ members of the public rather than ‘to’, ‘about’ or ‘for’ them”.
The term ‘public’ is used to include “patients, potential patients, carers and
people who use health and social care services as well as people from
organisations that represent people who use services” (INVOLVE, 2012, p.
6). The public involvement work (referred to throughout the thesis as PPI), 
which was conducted to support the feasibility study, is presented in this 
chapter. The aim of the PPI work was to explore OSA patients’ views
towards exercise in order to inform a protocol for a feasibility RCT examining
the benefits of exercise for obese people with OSA who undergo weight-loss 
surgery.
7.2 Methods
7.2.1 Participants
A questionnaire-based assessment of patients’ opinions about exercise
training was undertaken in the sleep clinic at JCUH in July 2016. A 
convenience sample of five patients (four males, one female) who were
being considered for weight-loss surgery (three patients referred from the
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specialist weight management services (SWMS) pathway and two patients 
referred from the bariatric pathway) and also had OSA completed the PPI
work. Formal ethical approval was not needed for this work but Sophie Suri, 
a postgraduate researcher at Teesside University looking at the topic of
exercise and OSA, possessed a research passport for JCUH (NIHR, 2014) 
(Appendix 11). All data was collected anonymously.
7.2.2 Data Collection
At the beginning of each patient’s appointment in the sleep clinic, they were
asked by the clinician if they would be willing to answer questions from a
short questionnaire about their opinions regarding a potential exercise
intervention prior to weight-loss surgery. If patients were agreeable, these
questions were asked at the end of their clinical appointment by Sophie Suri.
All questions were asked in a clear and sensitive manner after establishing a
brief rapport with the patient (Pandya-Wood, Barron and Elliott, 2017).
Members of the research team developed the questionnaire, which was 
based on a patient questionnaire previously used on surgical patients with
lung cancer in the development of a study protocol. However, the questions 
were edited accordingly for focus on OSA, weight-loss surgery and physical
activity. The Research and Development team within South Tees Hospitals 
NHS Foundation Trust (STHNHSFT) approved the final questionnaire before
its use with patients.
The questionnaire captured the patient’s sex and weight-loss surgery
pathway (SWMS or bariatric) and consisted of eight short closed questions 
(e.g. ‘How important do you think increasing your levels of exercise and
fitness might be for improving your current health status?’ Possible answers:
very important, important, somewhat important or not important at all). 
Patients were asked to choose one response for each question with the
exception of question seven, which allowed for multiple responses. Closed
questions were used to facilitate the collection of simple, structured data
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during a busy clinical period (Gratton and Jones, 2004). After the closed
questions, a filter question was asked. This filter question asked for a
‘yes/no’ answer with additional information required if the patient’s response
was ‘no’. Finally, an open question was asked, and patients were provided
with an opportunity to add any further comments or suggestions. The full 
questionnaire is presented in Appendix 12. 
7.2.3 Data analysis
Sophie Suri analysed the data. For closed questions, the frequency of each
response option was recorded and reported for each question. For open
questions, the variety of responses provided for each question were all
recorded and reported. This was feasible given the small sample size. An
overall summary and individual question summaries were then formulated.
No further data analysis was completed.
7.3 Results
7.3.1 Overall Summary
All five patients thought that increasing their levels of exercise and fitness
was important for improving their current health status and were willing to be
part of an interval-based exercise study, in either arm of the trial, provided all
travel expenses were paid. There was also a positive overall consensus for
keeping an activity log/wearing a pedometer to track daily physical activity
levels.
All patients stated that they would like to improve their weight, health-related
quality of life and symptoms of OSA in the study. Increasing physical activity,
exercise capacity and reducing the length of hospital stay after surgery were
also prioritised as important outcomes by the patients.
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Three out of five patients stated that they would want to provide study
feedback in a telephone interview with the researcher. Two out of five
patients said they would prefer to disclose this information in a researcher-
led interview or focus group.
Patients suggested that they thought appropriate questions to ask in the
study feedback should be related to a) how happy they were with the
exercise, b) whether they enjoyed the intervention, c) how they felt during
and directly after the exercise session (and in the immediate longer term e.g.
improved quality of life) and d) if the exercise caused them any pain or
dizziness. Table 7.1 presents the patient responses to the multiple-choice
questions in the public involvement questionnaire.
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7.3.2 Question summaries
Question One:
‘How important do you think increasing your levels of exercise and fitness
might be for improving your current health status?’
All five patients thought that increasing their levels of exercise and fitness
was important or very important for improving their current health status.
Question Two:
‘How would you feel about doing some supervised exercise lasting for a
maximum of one hour, twice a week, at Teesside University if your travel
expenses were paid for?’
Four patients were willing to attend Teesside University to do some
supervised exercise lasting for a maximum of one hour, twice a week,
providing that travel expenses were paid. One patient said they would
consider the exercise intervention if travel was fully organised (the patient did
not drive and struggled with mobility) and if their current physiotherapist was
happy with the intervention.
Question Three:
‘How would you feel if this exercise was done in short “chunks” lasting 30-60
seconds where you would become out of breath but then there would be
some rest periods in between?’
All five patients felt happy to do exercise in short “chunks” lasting 30-60
seconds where they would become out of breath but then there would be
some rest periods in between.
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Question Four:
‘Would you be willing to keep a written log of how much physical
activity/exercise you do during every-day activities?’
Three patients were happy to keep a written log regarding their physical
activity during every-day activities. One patient said they would possibly
consider keeping a log. One patient who was unable to write said they would
be happy to keep a log if there was a format that allowed them to do this.
Question Five:
‘Would you be willing to wear a pedometer type tracker (worn on the waist) to
measure how much physical activity/exercise you do during every-day
activities?’
Four patients said they would be willing to wear a pedometer-type tracker
(worn on the waist) to measure their physical activity/exercise levels during
every-day activities. One patient used a mobility aid and did not think this
would be applicable to their situation.
Question Six:
‘Anyone who is involved in this study would have about a 33% chance of
being allocated to a no-exercise “control” group rather than the group who
receive the exercise training. Here, you would receive all the treatment you
would normally get, but you would not be given any supervised exercise.
However, health measurements would be obtained from you at various times
before and after your surgery. Would this affect your willingness to be
involved in the study?’
All five patients were happy to be part of the control group if they were not
part of the exercise group.
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Question Seven:
‘Which health measures (you can choose more than one) would you want to
improve in the study?’
Five patients said they would like to improve their weight, health-related
quality of life and symptoms of OSA in the study. Four patients said they
would like to improve their physical activity and exercise capacity and two
patients wanted to reduce the length of hospital stay after surgery.
Question Eight:
‘During a study, feedback from patients about the exercise programme is
very important. How would you feel most comfortable providing us with this
information if you were in this position?’
Patients said they would prefer to give study feedback in a telephone
interview (three patients), a focus group (one patient) or a face-to-face
interview (one patient) with the researcher.
Question nine:
‘Hypothetically, would you be interested in participating in a study of this
kind?’
All five patients said they would hypothetically be interested in taking part in
a study of this kind.
7.3.3 Further patient comments
Patients suggested that they thought appropriate questions to ask in the
feedback part of the study should concern:
a) Whether they were happy with and enjoyed the type of exercise
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b) How they felt during and directly after the exercise session
c) Whether the exercise caused them any pain or dizziness
d) Whether they felt better in the longer term (e.g. improved quality of life)
One patient was concerned about the length of each exercise session. They
felt unsure as to whether they would be able to complete a full session but
said they would be willing to do what they could. NB: It was noted that
patients in this population group had other health conditions/comorbidities.
7.4 Discussion
In this chapter, OSA patients’ views towards exercise were explored in order 
to inform a protocol for a feasibility RCT examining the benefits of exercise
for obese people with OSA who undergo weight-loss surgery.
The preliminary logistics of the trial were well received by the patients. A 
RCT involving two supervised hour-long exercise sessions, twice weekly, at 
Teesside University appears to be a feasible design framework for a protocol
provided that travel expenses are covered. Also, all patients were happy with 
the proposed interval design. One patient had concerns regarding mobility
issues, indicating an area for consideration regarding modes of exercise and
potential venues in the protocol design in chapter eight. The same patient
also expressed concern regarding the acceptability of the exercise
intervention by their physiotherapist. Developing information leaflets for 
patients to give to members of their care team prior to study enrolment may
be an option to explore to facilitate multidisciplinary team guidance and
support.
When choosing outcome measures for an exercise intervention, it is 
imperative that they reflect the benefits that patients want to see from their 
participation. Weight, health-related quality of life and symptoms of OSA
were unanimously agreed as important trial outcomes by the patients, with 
four out of the five patients also wanting to increase their fitness and physical
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activity levels. Therefore, it is important to include these outcomes in the
protocol in order to increase trial relevance and ‘success’ from both patient
and clinical perspectives (Yordanov, Dechartres and Ravaud, 2018). Only 
two patients indicated that length of hospital stay after surgery was a health
measure they wanted to improve. Including this outcome measure in the 
protocol, which does not require great expense or time to document, is still
considered important as it could add value to the research for the wider 
population group. Such data also provides value when viewing the research
from an economic perspective.
The measurement of one of the proposed trial outcomes (daily physical
activity levels) was identified as a potential concern during the PPI work. The 
written format of recording physical activity levels was brought to attention by
one patient who was not able to write. Measurement of daily steps using a
pedometer-type tracker worn on the waist was also identified as problematic 
by one patient who used a mobility aid. Consequently, alternative subjective
(e.g. voice recorder option) and objective methods of recording activity need 
to be investigated in order to reliably, accurately and sensitively capture daily
physical activity levels in this population group (Warms, 2006). These
alternative methods could be explored in the feasibility trial itself.
The patients’ initial awareness of the importance of exercise for improving
their health status and their desire to improve their physical activity levels 
was highly encouraging. However, patients awaiting bariatric surgery are
reported to be quite sedentary, with physical and psychological barriers to
exercise often reported (King and Bond, 2013; Zabatiero et al., 2016).
Therefore, careful consideration is needed in the trial design regarding how
to remove/work around as many barriers to exercise as possible and help 
translate this patient group’s knowledge and desire into action.
The Questionnaire data suggested that one of these barriers to exercise is 
physical health, a finding supported by previous research with obese adults 
(King and Bond, 2013; McIntosh, Hunter and Royce, 2016). As recognised in
112 
       
         
          
        
        
 
       
          
         
        
        
         
     
        
  
 
         
          
        
         
          
        
        
           
           
         
          
           
          
          
   
 
 
the PPI work, weight-loss surgery candidates often have physical limitations 
due to the presence of comorbidities (Guh et al., 2009). Consequently,
particular attention needs to be given to the design of the exercise
programme (e.g. employing lower impact exercise options) to increase trial
safety, accessibility and support-desired outcomes (Hoffmann et al., 2016).
A further barrier to exercise, which was addressed by one patient, was 
concern about their ability to complete the exercise regime due to poor 
physical fitness, a view not uncommon in the literature (King and Bond,
2013; McIntosh, Hunter and Royce, 2016). Therefore, progressing exercise
gradually, providing increased support and setting achievable targets and
starting points to help patients gain confidence are highly important design
considerations. Addressing these points may also optimise enjoyment and 
limit pain, which were highlighted as valued feedback factors by the patients 
regarding exercise.
Prior to concluding the findings from this chapter, the limitations of the PPI
work conducted must be discussed. First of all, the questionnaire method
employed to obtain the required information did not allow patients to respond
in-depth about their opinions on exercise and physical activity (Gratton and
Jones, 2004). However, it is felt that enough information was captured to
inform the preliminary stages of the design process. A second potential 
limitation is the fact that the PPI work was completed by a male dominated 
convenience sample. Although this may limit the ability to generalise from the
results, it is argued that the current work is still highly beneficial to informing
the feasibility study for the following reasons; a) Patients were only being
asked for their opinions on exercise and had little reason to not provide this 
information, b) the views obtained were from a directly relevant patient group
and c) the results obtained did corroborate with past research in this area
(Gratton and Jones, 2004; King and Bond, 2013; McIntosh, Hunter and
Royce, 2016).
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7.5 Conclusion
The PPI work conducted in this chapter has provided invaluable information
to inform the concluding chapter of the thesis, which presents a protocol for a
feasibility RCT examining the benefits of exercise for obese people with OSA 
who undergo weight-loss surgery. From the data collected, it appears that a
supervised interval-based exercise RCT at Teesside University is acceptable
in this patient group. However, it is important that the potential patient
barriers and other highlighted considerations from this work are incorporated
into the following protocol to maximise trial success and ultimately enhance
research impact.
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Chapter Eight: The benefits of exercise for obese people with 
obstructive sleep apnoea who undergo weight-loss surgery: 
A protocol for a feasibility trial
8.1 Introduction
Weight-loss surgery candidates have a high risk of OSA (Chung, Abdullah
and Liao, 2016), adhere poorly to current treatment (CPAP) (Thomas et al.,
2013) and often present with low levels of cardiorespiratory fitness 
(McCullough et al., 2006). These factors increase this clinical population’s 
perioperative risk (e.g. from OSA-related complications and decreased
functional capacity), which could adversely affect patient health and
potentially lead to an increased economic burden to healthcare (Dawson,
Singh and Chung, 2016; Tew et al., 2018).
The beneficial effects of exercise on cardiorespiratory fitness and OSA 
severity (chapter three) provide a platform for exploration to address the
above concerns in a ‘prehabilitation’ context (Iftikhar, Kline and Youngstedt,
2014; Iftikhar et al., 2017). Prehabilitation refers to “the process of enhancing
an individual’s functional capacity to enable them to withstand a forthcoming
stressful event” such as major elective surgery (Snowden and Minto, 2015.
p.187). Improving the functional capacity and OSA severity of weight-loss 
surgery patients through a structured, purposeful preoperative exercise
programme may reduce perioperative complications, reduce the length of
hospital stay and engage these patients in a longer-term preventative model
of healthcare (Speake et al., 2016; NHS, 2017; Tew et al., 2018).
Exercise training has been reported to improve OSA severity in non-bariatric 
patients (Iftikhar, Kline and Youngstedt, 2014; Iftikhar et al., 2017) and the
cardiorespiratory fitness of bariatric patients (Carver et al., 2011; Onofre et 
al., 2017.) It is unknown at present whether exercise can improve OSA 
severity and cardiorespiratory fitness in weight-loss surgery patients with the
disorder. Randomised controlled trials with specifically designed preoperative
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exercise training programmes in different clinical populations have been
called for to bridge this gap (Tew et al., 2018). Therefore, in this chapter of
the thesis, a protocol for a feasibility RCT examining the benefits of exercise
for obese people with OSA who undergo weight-loss surgery is presented.
Feasibility studies are viewed as an integrated part of pilot work by some
authors and institutions (NIHR, 2016). However, the NIHR view feasibility
and pilot studies as distinct separate activities, with feasibility work driven by
information needs and predominantly concerned with estimating unknown
parameters (e.g. recruitment, adherence and retention figures) to examine
whether a full-scale trial is viable (NIHR, 2016). Under the NIHR definition, 
pilot studies involve a small scale testing of the actual larger trial to
determine if key study elements run smoothly (NIHR, 2016). This work will be
categorised as a feasibility study (adopting the NIHR definition) as the main
aim is to estimate important parameters to inform the design of a subsequent
definitive trial.
8.1.1 Aim
The primary aim of this chapter was to develop a sound protocol, informed
by information collected in previous chapters and from the literature base in
general, to assess the feasibility and acceptability of delivering an exercise
intervention to obese patients with OSA who undergo weight-loss surgery.
8.1.2 Ultimate objectives that inform the protocol design
1. Determine the variability (standard deviation) of potential outcome
measures for a subsequent definitive trial
2. Assess the feasibility of measuring the proposed outcome measures
3. Examine feasibility and acceptability parameters to assess study
viability (e.g. number of eligible patients; recruitment, retention and
adherence figures) 
4. Examine the acceptability by clinicians of delivering this trial in the
existing clinical pathway for weight-loss surgery patients with OSA 
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5. Assess study safety (number of adverse events directly related to the
intervention)
6. Determine realistic study timescales for a full trial
8.2 Methods
8.2.1 Study design
This work will be a single-centre, two-arm, parallel-group, randomised 
controlled feasibility study (Figure 8.1). The study will be a collaboration
between people from two institutions; one clinical and one academic.
8.2.2 Participants
Weight-loss surgery patients who have been identified as having a high
likelihood of OSA from preoperative screening/testing are seen in the sleep
clinic at the clinical institution for formal diagnosis and treatment initiation. A 
researcher will approach weight-loss surgery patients who potentially meet
the study inclusion criteria directly after this appointment and ensure they
meet all inclusion criteria. Patients interested in the study will be provided
with a participant information sheet. Additional information leaflets for 
patients to give to members of their care team prior to study enrolment will
also be made available. A researcher will contact (by telephone) patients 
who have expressed interest in participation at the clinic. Patients willing to
take part in the study will be scheduled for initial cardiopulmonary exercise
testing (CPET) once verbal consent is gained.
All CPET will be conducted at the clinical institution under strict supervision
one week prior to baseline testing. CPET will follow protocols similar to those
used previously with this population group (Hennis et al., 2012; Lanzi et al.,
2015). The CPET will act as a final screening measure and will also facilitate
exercise prescription (Figure 8.1). 
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Study inclusion criteria:
• " 18 years old
• Weight-loss surgery patient
• Diagnosed using routine clinical testing procedures as having
moderate to severe OSA (AHI " 15)
• CPAP therapy has been initiated at preoperative assessment in the
sleep clinic 
• Meet no study exclusion criteria as determined using internationally
recognised guidelines for exercise testing and prescription (The
American College of Sports Medicine (ACSM), 2014).
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Figure 8.1: Study flow-chart (CPET = cardiopulmonary exercise testing)
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8.2.3 Randomisation and sample size
After CPET and baseline assessments, patients will be randomly allocated
2:1 (to place emphasis on the exercise intervention process) to intervention
(usual care and exercise) or usual care control (no exercise). Minimisation 
will be used to ensure balance across trial arms for important prognostic 
factors such as age and sex. The study statistician will conduct the
minimisation process remotely via email. Previous PPI work (chapter seven) 
indicated that patients are willing to be randomised to either group in this 
study.
Sample sizes between 24 and 50 have been suggested for use in pilot
studies (Julious, 2005; Sim and Lewis, 2012). Therefore, the current study
will recruit 42 patients (28 patients in the intervention arm and 14 patients in
the usual care control arm). Approximately 100-150 bariatric patients are
screened annually at the clinical institution for OSA and prevalence rates of
moderate to severe OSA are > 45% in this population group (Kositanurit et 
al., 2018). An 18-month period for recruitment is deemed appropriate to
achieve a total sample size of 42 patients.
8.2.4 Exercise intervention
The exercise intervention will take place in an easily accessible location at 
the academic institution, which patients confirmed as acceptable in the PPI
work (chapter seven). Safety governance measures will be strictly adhered to
throughout the programme (see section 8.4). This programme has been
informed by previous interventions on non-bariatric individuals with OSA that
have been completed successfully and safely (Kline et al., 2011; Sengul et 
al., 2011) and exercise interventions/guidelines relating to bariatric 
populations (Pouwels et al., 2015, King and Bond, 2013). In chapter seven, 
patients were only asked if they would be willing to complete two training
sessions per week (and were willing to do this) and about interval-based
exercise. However, the frequency of training has been increased in the
current intervention (to three sessions per week) and the protocol based on
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continuous moderate-intensity aerobic work as these prescriptions were
found to be more in-line with the research used to inform the programme
design.
Patients in the exercise group will receive routine clinical care and also
perform supervised moderate-intensity aerobic exercise and resistance
training three times per week for the 12-week period leading up to weight-
loss surgery. Each session will last approximately 60-70 minutes (warm-up, 
30 minutes moderate-intensity aerobic work, 20 minutes resistance training,
cool-down). The exercise modalities (cycling on a stationary bike or walking
on a treadmill) chosen provide low-impact options for a population group who
may be limited by comorbidities (Guh et al., 2009). Light resistance training
(upper body, lower body and trunk) with dumbbells and bands will be 
completed in mini-circuit formats.
Exercise intensity will be prescribed using information from each patient's 
CPET, which is considered to be the ‘gold standard’ test for evaluating
exercise capacity (Stroescu et al., 2012). CPET brings a high level of
objectivity in exercise tolerance evaluation and provides information on
multiple physiological parameters, which are needed for accurate and
individualised exercise prescription (Stroescu et al., 2012). Exercise intensity
during the intervention will be monitored using heart rate domains and
ratings of perceived exertion (RPE) – measured using Borg’s CR-10 scale
(Borg, 1982). RPE has been shown to be an acceptably reliable and valid
marker of exercise intensity in obese people (Jakicic et al., 1995).
Blood pressure will be checked at regular intervals (e.g. before training, post
warm-up, post aerobic training). Exercise will be progressed gradually
throughout the 12-weeks and longer warm-up and cool-down periods 
employed for safety. Two experienced exercise scientists will ensure
treatment fidelity throughout the intervention. Patients will also receive one
weekly individual face-to-face counselling session with a trained psychologist
to support their exercise participation. These sessions will take place prior to
and at the same location as the intervention. The usual care control will
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follow routine clinical care throughout this period but will not take part in the
exercise intervention.
8.2.5 Outcome measures
For this feasibility trial the emphasis will be focused primarily on the
feasibility, acceptability and safety indicators:
1. Eligibility numbers: number of patients who meet the study inclusion
criteria (number of patients per month over an 18-month period) 
2. Recruitment figures: number of patients recruited to the study over 
time (number of patients per month over an 18-month period)
3. Exercise adherence: % of patients completing "75% of exercise
programme sessions
4. Retention figures: % of patients who have complete data collection
5. Clinicians acceptability of the trial: assessed in a researcher-led focus 
group at the hospital institution with 8-12 healthcare professionals 
responsible for the care of weight-loss surgery patients with OSA
6. Patient acceptability of the exercise intervention: previous PPI work 
(chapter seven) indicated a preference for study feedback to be given
in a telephone interview with a member of the research team.
Therefore, researcher-led semi-structured telephone interviews will be
conducted with all patients in the exercise group. Questions will focus 
on those identified as important regarding study feedback from the
PPI work (how happy patients were with the exercise, whether they
enjoyed the intervention, how they felt during and directly after the 
exercise session (and in the immediate longer term e.g. improved
quality of life) and if the exercise caused them any pain or dizziness).
7. Study safety: number of adverse events directly related to the trial
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The variability (standard deviations) of the following outcome measures will
be examined to inform sample size planning for a subsequent definitive trial:
Primary Outcomes
• OSA Severity: Apnoea/hypopnoea index measurement using the
Embletta portable diagnostic system, which has been validated
against hospital-based polysomnography (Ng et al., 2010). Patients 
will use this system at home.
• Daytime sleepiness: The Epworth Sleepiness Scale, which is a 
validated questionnaire for assessing daytime sleepiness (Johns,
1991; Johns, 1993).
• Cardiorespiratory fitness: The 6-Minute Walk Test has been reported
to be a valid predictor of the anaerobic threshold (Sinclair et al., 2012) 
and has been used previously to assess functional capacity in
bariatric surgery patients (deSouza et al., 2009). This simple field test
is less resource intensive and more feasible to use than CPET for 
evaluation of cardiorespiratory fitness pre and post intervention
(Stroescu et al., 2012).
Secondary Outcomes
• Total daily physical activity levels: measured over a 7-day period
using physical activity diaries and triaxial accelerometry at the hip
(Actigraph GT3X). The PPI data collected in chapter seven indicated
that these potential data collection tools might need to be further 
investigated once the sample is recruited.
• BMI
• Health-related quality of life: The EuroQoL EQ-5D, which has been
previously validated in clinical settings (Jia and Lubetkin, 2005).
• Length of critical care and hospital stay
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8.2.6 Baseline and post-intervention assessments
Written informed consent will be gained before any tests are conducted. 
Baseline assessments will then be conducted for both groups. Baseline
assessment will include patient characteristics (age, sex and BMI) and
examine daytime sleepiness (Epworth Sleepiness Scale), cardiorespiratory
fitness (6-Minute Walk Test) and health-related quality of life (EuroQoL EQ-
5D). Home-based polysomnography will also be conducted and patients will 
be asked to record their physical activity levels for the following week,
reporting back to the researcher as instructed.
All patients will also conduct post-intervention assessments one week prior 
to surgery. Assessments will be conducted at the academic institution and
follow the safety procedures identified in section 8.4. Researchers blinded to
group allocation will collect baseline and post-intervention assessment data.
A clinical member of the research team will obtain length of critical care and
hospital stay from patient records following discharge.
8.2.7 Data analysis
The study statistician will conduct the statistical analysis in a blinded manner.
Data analysis will be on the basis of intention to treat. The standard deviation
of the changes in the outcome measures will be quantified along with 95%
confidence intervals. The effect of exercise training on the outcomes will be
analysed using a general linear model, including group as a fixed factor and
baseline measures as a covariate. As this is a feasibility study and not
concerned with effect size, no further evaluation of the outcome measures 
will be conducted (NIHR, 2016). The qualitative data from focus groups with
healthcare professionals and telephone interviews with patients will be
recorded, transcribed verbatim and analysed using thematic analysis 
(Gratton and Jones, 2004). Data management will abide by the governance
guidelines of the two study institutions. The trial will be reported using the
CONSORT guidelines as extended for the reporting of randomised pilot and 
feasibility trials (Eldridge et al., 2016).
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8.3 Criteria for Success
A subsequent definitive RCT will be viewed as feasible if the following criteria
are met:
1. " 80% of patients have complete data collection
2. " 80% of patients achieve the adherence criteria (i.e. complete "75% 
of exercise sessions)
3. There are no major concerns identified regarding acceptance of the
intervention by patients and clinicians 
4. The primary outcome measures have been confirmed and the
associated standard deviations quantified for powering a definitive trial
5. The monthly eligibility and recruitment figures suggest that it is 
feasible to plan an adequately powered definitive trial with a realistic 
recruitment timeframe
6. Measurement methods for all outcomes have been confirmed
7. There are no adverse events directly linked to the trial
8.4 Research governance and monitoring
Approval for the study will be gained from the school ethics committee at the
academic institution and the NHS Research and Development Office at the
clinical site. NHS Research Ethics Committee and Health Research Authority
(HRA) approvals will then be obtained. No study activity will commence until
all approvals are completed. Study conduct will adhere to the Declaration of
Helsinki (World Medical Association, 2013) and principles outlined in the UK 
Policy Framework for Health and Social Care Research (HRA, 2017). Where
relevant, NHS research passports will be gained prior to the start of any
research.
Two groups will manage the study, a research management group and a
steering group. The research management group will receive weekly updates 
from the research team and meet monthly to discuss study progress/highlight
any problems. The steering group will be led by an academic independent of
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the two study institutions and will receive monthly updates from the research
management group. This group will meet once every three months to ensure
that the study is adhering to all guidelines and protocols and identify any
areas of concern.
All adverse events will be recorded with both the research management and
steering groups informed. Reporting will follow the HRA (2018) safety
reporting guidelines. Adverse events will be detailed in all study documents 
and publications. All exercise testing and prescription will follow ACSM
guidelines (Thompson et al., 2007). The following control measures will also
be implemented to reduce the risk of adverse events:
• Thorough pre-participation screening
• Exclusion of high-risk patients
• Exercise sessions supervised by experienced research
nurses/exercise scientists trained in immediate/advanced life support
• Exercise sessions performed in the afternoon given the higher 
frequency of cardiovascular events during the early morning hours 
• Prompt evaluation of prodromal symptoms
• Longer warm-up and cool-down periods
• Resuscitation equipment and oxygen immediately available
• Exercise termination if a patient experiences chest, back or 
abdominal pain, dizziness or an increase in systolic blood pressure
to >180 mm Hg
Participants requiring further assessment will be transferred to the accident
and emergency unit at the local clinical institution by a member of the
research team or an ambulance if it is a medical emergency. The clinical
institution will be informed of the study training and testing times and dates.
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8.5 Patient and public involvement 
The patient and public involvement (PPI) work conducted in chapter seven
has provided invaluable information to inform the development of this 
protocol. PPI work will continue to inform the study to ensure that all work is 
acceptable and receives input from a patient perspective (patient 
representatives included in the research management and steering groups). 
All PPI work will follow INVOLVE (2012) guidance.
8.6 Dissemination
1. Academic dissemination: The feasibility study will be published in a
high impact journal. The findings will also be presented at international
and national conferences e.g. the annual congress of The Association
of Anaesthetists of Great Britain and Ireland (AAGBI).
2. Patient-centred dissemination: Seminars/events pertaining to the
research will be held at the two participating institutions for patients 
and relevant healthcare professionals to attend.
3. Public dissemination: A news item pertaining to the research will be
written and sent to relevant organisations and groups (e.g. British
Lung Foundation).
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Chapter Nine: Overview and conclusions to this thesis
9.1 Overview of the findings: the diagnosis of OSA
It has been reported that a substantial number of people with OSA, even 
those with obesity, remain formally undiagnosed (Rejon-Parrilla, Garau, and
Sussex, 2014; Chung, Abdullah and Liao, 2016). Therefore, one of the aims 
of this thesis was to examine how the relationship between physical activity
and SDB could be used to improve OSA screening. In chapter four, it was 
found that a simple ‘yes/no’ question pertaining to self-reported slow-walking
speed was independently associated with SDB outcomes in the large
population-based dataset from the MESA. It was also reported that this 
easily answered question had a good response rate (98%) and compared
favourably with other items present on existing OSA screening tools such as 
the STOP-Bang.
Figure 9.1: Clinical pathway for diagnosing and treating OSA in adults
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Early detection of disease is an important component of current health 
care policy (Public Health England (PHE), 2016). At present, patients 
usually present to their general practitioner (GP) with signs of OSA such
as excessive daytime sleepiness or very loud snoring (NHS, 2016). If
OSA is suspected, the patient will be referred to a sleep specialist who 
will evaluate them for the disorder and determine if further testing is 
needed (NHS, 2016). These initial evaluation processes are based on
patient history, clinical examination and screening questionnaires such as 
the STOP-Bang (British Lung Foundation, 2012; NHS, 2016). Figure 9.1
shows the current clinical care pathway for diagnosing and treating OSA 
in adults in the UK. The initial results from the thesis indicate that a
patient’s walking speed may help to identify whether they are likely to
have OSA. Improving screening with a quick and simple walking speed
question could have great benefits for OSA sufferers, as it would increase
their chance of being identified and triaged for further testing and
ultimately treatment to improve their health and quality of life. Without
being identified, a person would continue to struggle with the disorder and
its consequences and spend more time trying to find an answer for highly
debilitating symptoms. This would impact negatively on the economy,
especially the NHS with regards to the significant vascular comorbidities 
associated with untreated OSA (e.g. myocardial infarction, stroke) (Rejon-
Parrilla, Garau and Sussex, 2014; Dawson, Singh and Chung, 2016).
Further work is needed, but these preliminary findings suggest that
clinicians should consider walking speed during their patient evaluation.
In chapter six, the findings from chapter four were progressed into a clinical
context with weight-loss surgery patients, a group with a high prevalence of
OSA (Chung, Abdullah and Liao, 2016). Efficient diagnosis and treatment of
OSA is particularly important in these patients to reduce the risk of
perioperative OSA-related complications (Riad and Chung, 2013). The work 
in this chapter examined whether replacing the BMI item in the STOP-Bang
questionnaire, which is usually positive for all members of this population
group, with a slow-walking speed item could improve its screening utility.
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When the slow-walking speed item was added to this new model
(STOPANG), it improved the area under the ROC curve from 0.64 to 0.70.
Slow-walking speed was also found to be a more important factor than
several other existing items on the STOP-Bang tool such as snoring, daytime
sleepiness and hypertension. 
In the current clinical pathway, all patients referred to bariatric and SWMS
clinics at JCUH complete the STOP-Bang screening tool located on the
referral form during their first clinical evaluation with a bariatric nurse
specialist. Figure 9.2 shows the clinical care pathway for this patient
group. The key findings from the current work suggest that a question
pertaining to slow-walking speed could help to identify more patients with
a high likelihood of OSA before they undergo weight-loss surgery.
Identification prior to surgery could ultimately reduce the number of
patients at risk of OSA-related surgical complications and the added
trauma that these may involve (Riad and Chung, 2013; Chung, Abdullah
and Liao, 2016). As discussed in chapter six, improved screening with a
slow-walking speed question would also be advantageous for the clinical
care team, as they would be more prepared for surgeries (e.g. have
appropriate perioperative management plans in place such as increased
patient monitoring and caution when using opioids as they can worsen
OSA) (Danjoux and Habgood, 2016; Dawson, Singh and Chung, 2016).
Therefore, the results from this thesis could ultimately lead to a safer and
more efficient clinical care pathway for weight-loss surgery patients with
OSA. Further research is most definitely warranted to examine these
preliminary findings.
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9.2 Overview of the findings: the treatment of OSA
Poor adherence to CPAP, the ‘gold-standard’ treatment for OSA, and 
incomplete efficacy of secondary therapies (e.g. MADs, weight loss) pointed
to the need for alternative management strategies for this debilitating
disorder (NICE, 2008). The beneficial impact of exercise on OSA was 
recognised as a potential solution to the problem, yet further work to expand
the evidence base regarding the effects of exercise on the severity and
symptoms of OSA had been called for (Iftikhar et al., 2017). Therefore, the
treatment pathway in the thesis aimed to consolidate the existing body of 
knowledge on this topic (conducting an overview of reviews on the effects of
exercise on OSA) and undertake important preparatory work (examining a 
potential outcome measure and conducting PPI work) towards the design of
a high-quality RCT to advance the research body.
Firstly, the critical overview of reviews provided evidence to suggest that in
adults with OSA (on average reviews reported data on generally healthy
males and females who were >40 years old with AHI >15 events/h and BMI
>25 kg/m2), exercise has a significant and potentially clinically meaningful
effect on reducing OSA severity and daytime sleepiness, independent of
BMI. From this chapter, it was concluded that currently, despite some
variability between reviews regarding the size of effect (AHI reductions 
between 4.66 and 17.23 events/h were reported in RCT-only meta-
analyses), there is a robust research body supporting the use of exercise as 
an “adjunctive therapy” option for the management of OSA (Iftikhar et al.,
2017. p. 12).
These results are highly encouraging and indicate that exercise may be
another strategy to help treat this disorder (Figure 9.1). Therefore, clinicians 
should ensure that the benefits of exercise for improving OSA are explained
and highlighted to patients and encourage them to incorporate exercise into
their management programmes. Exercise may be welcomed by many
patients struggling with current therapy options, especially as the amount of
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exercise needed to see beneficial effects is not excessive and even less than
the physical activity guidelines for adults (NHS, 2018). Reviews in chapter 
three indicated a trend towards regimens that were conducted three times 
per week and included ! 30 minutes moderate intensity aerobic exercise + 
resistance training (Araghi et al., 2013; Iftikhar, Kline and Youngstedt, 2014;
Aiello et al., 2016; Iftikhar et al., 2017). For example, if a patient was using
CPAP but struggling to adhere to it and therefore not getting optimal benefits,
the addition of exercise to their management plan could make up for any
shortfalls in their CPAP usage and keep their OSA in a lower severity
category. Likewise, if a patient had a milder form of the disorder and could
not use MADs, exercise may be able to bring their OSA to a manageable
level. Also, unlike CPAP and MADs, the side effects of exercise are more
positive e.g. exercise may lead to improvements in cardiorespiratory fitness 
(Iftikhar, Kline and Youngstedt, 2014).
In particular, it is promising that the preliminary evidence indicates that
exercise could provide patients with an effective strategy to deal with
excessive daytime sleepiness, which may not be addressed as well with
other treatment options (Bratton et al., 2015; Iftikhar et al., 2017). Improved
management of this functionally limiting symptom would enable patients to
be more effective in their everyday lives and safer when driving, increasing
quality of life and work productivity and decreasing the number of OSA-
related road traffic accidents (Rejon-Parrilla, Garau and Sussex, 2014). This 
could help the economy as it’s estimated that the cost of one fatal road traffic 
accident can be as much as £1.5 million (British Lung Foundation, 2012).
As highlighted in figure 9.2, weight-loss surgery patients identified as 
having OSA are treated for the disorder prior to surgery as part of routine
clinical care. Usual clinical care involves CPAP used 8-12 weeks 
preoperatively (NICE, 2008; Danjoux and Habgood, 2016). Although 
exercise had been shown to have benefits for treating OSA in adults, no
studies had examined whether exercise in the preoperative period could
help to improve this patient group’s OSA and guidance for providing safe
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and effective exercise prior to elective major surgery was limited (Iftikhar,
Kline and Youngstedt, 2014; Iftikhar et al., 2017; Tew et al., 2018). The
patient-informed protocol in this thesis provides the crucial early steps 
needed to initiate potential improvements to clinical care for this high-risk 
patient group (Dawson, Singh and Chung, 2016). Improving the
preoperative stage of the clinical pathway by adding exercise alongside
CPAP could enable patients to enter the perioperative period with greater 
physiological reserve and less severe OSA, reducing perioperative risk 
and potentially improving recovery and minimising the length of hospital
stay (Dawson, Singh and Chung, 2016; Tew et al., 2018). This would
decrease the strain on the patient’s support network and clinicians and
reduce health care costs (Dawson, Singh and Chung, 2016). It would also
place patients at a vantage point for furthering their weight loss post
surgery, especially as they may have established a regular habit of
exercise during the preoperative phase (Tew et al., 2018). A brief
overview of the protocol is provided in figure 9.3.
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Aim: The aim of the trial is to assess the feasibility and acceptability of
delivering an exercise intervention to patients with OSA who undergo
weight-loss surgery in order to examine whether a full-scale trial is 
viable (NIHR, 2016).
Methods: Forty-two weight-loss surgery patients with clinically 
diagnosed moderate-to-severe OSA will be randomly allocated 2:1 to
intervention (usual care and exercise) or usual care control (no
exercise). The intervention group will perform 60-70 minutes of
supervised, low-impact, moderate-intensity aerobic exercise and
resistance training 3 times per week for the 12-week period leading up
to surgery. Patients will also receive one weekly individual face-to-face
counselling session with a trained psychologist to support their
participation. Feasibility, acceptability and safety indicators will be
assessed throughout an 18-month recruitment period, during the 12-
week intervention and post patient discharge. Outcomes to be
assessed prior to randomisation and one week prior to surgery include
OSA severity, daytime sleepiness, cardiorespiratory fitness, quality of
life and daily physical activity-levels. Length of critical care and hospital
stay will be recorded at patient discharge. The standard deviation of
the changes in the outcome measures will be quantified along with
95% confidence intervals to inform sample size planning for a definitive
trial. Qualitative data will be analysed using thematic analysis. Criteria
for success related to the above indicators and outcomes will be
reviewed once all data is collected to determine whether a full definitive
trial is warranted.
Ethics and Dissemination: NHS Research Ethics Committee and
Health Research Authority approvals will be obtained for this work.
Findings will be disseminated through academic journals and
conferences, patient-centred seminars and relevant national health
organisations.
Figure 9.3: The benefits of exercise for obese people with OSA who
undergo weight-loss surgery: A protocol for a feasibility trial
A final point to note from the treatment pathway of this thesis is that
pertaining to the work from chapter five regarding FMD%, a purported
early indicator of atherosclerosis, which is reported to be reduced in
people with OSA (Ali et al., 2014). The results from this chapter indicate
that people with OSA do not actually demonstrate a clinically important
reduction in flow-mediated dilation when data is analysed using more
appropriate allometric-based statistical methods (Atkinson et al., 2016).
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This finding indicated that FMD% was not suitable for use as an outcome
measure in the protocol presented in chapter eight (FMD% was proposed
to be the outcome measure pertaining to the cardiovascular 
consequences of OSA in this trial) and also highlighted that future
researchers need to be cautious when interpreting the literature and
analysing data regarding flow-mediated dilation in OSA patients.
9.3 Strengths and limitations of this thesis
There are a number of strengths to this thesis and also some limitations 
as highlighted within each chapter, the principal of which will now be
discussed. To begin with, the work conducted in this thesis was novel and 
has the potential to advance the diagnostic and treatment pathways for 
OSA. The overview of reviews, which was conducted in a systematic and
comprehensive manner, is the first of its kind to provide a detailed critique
and examine the consistency and quality of current meta-analyses on the
topic of exercise as a treatment for OSA. This comprehensive and clear 
document could improve the “uptake and application of knowledge” by
busy health care professionals who may not have the time to collate and
read multiple research papers (Pollock et al., 2016, p. 2). This is also the
first body of work to examine how physical activity could be used to
improve the diagnosis of OSA, as no screening tools have, to date,
included an item pertaining to a slow-walking speed. Another strength is 
that the datasets used for the analyses in chapters four and five were
from a large, population-based, multi-ethnic study. The research in these
chapters was adequately powered and can be generalised to people from
different ethnic groups. Also, throughout the thesis great attention was 
taken to ensure that appropriate statistical techniques were employed for 
all data analyses, which increases confidence in the results obtained.
Finally, all of the studies conducted as part of this thesis found a similar 
trend regarding the relationship between physical activity and OSA, which
adds strength to the overall conclusions drawn from this work.
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However, there are also limitations to the research presented, which need
to be acknowledged. Firstly, in chapter three it was observed that there
were a number of quality-related issues (e.g. reporting errors, publication
bias) across the reviews, which need to be considered when examining
the conclusions drawn from this work. Secondly, it is felt that the
AMSTAR tool used to judge the methodological quality of the four reviews 
might not have provided the most appropriate assessment of all four
papers. However, there was limited and conflicting guidance available
regarding the optimal tool for use when assessing the quality of
systematic reviews in the overview process (Pollock et al., 2016). A 
further limitation of the thesis pertains to the work conducted in chapters 
four and five. As this research was based on cross-sectional data, one
can only speculate about proposed causal mechanisms. Yet, the fact that
the results support the predominant theme found within the thesis and the
literature regarding the relationship between SDB and exercise does 
strengthen the inferences made in chapter four. A final limitation is that
PSG was not used for SDB diagnosis in chapters four, five and six. In the 
MESA, SDB was self-reported on a questionnaire, and in the clinical work 
in chapter six, diagnosis of OSA was a likely diagnosis based on oximetry
data from a relatively small sample of patients (N = 122). These principal
limitations of the thesis need to be taken into account when making final
evaluations of the evidence presented.
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9.4 Overall conclusions to this thesis
This thesis has examined the role of physical activity in the diagnosis and
treatment of OSA. Overall, there was a consistent message throughout
supporting the independent relationship between increased physical
activity and decreased OSA severity. 
Concerning the diagnosis of OSA, the work presented in this thesis has 
the potential to improve public health by facilitating early detection of
disease (PHE, 2016). The novel findings presented indicate that a simple, 
self-reported slow-walking speed question has the potential to:
a) Improve screening for OSA in adults.
b) Improve the diagnostic utility of the STOPANG tool in weight-loss 
surgery patients.
Effective management of OSA is essential for improving health and 
wellbeing and enabling people to fulfil meaningful roles within their 
families and wider society (PHE, 2016). The encouraging body of work 
presented in this thesis suggests that:
a) There is a robust evidence-base supporting the use of exercise
as an “adjunctive therapy” for treating the severity and symptoms 
of OSA in adults (Iftikhar et al., 2017. p. 12).
b) People with OSA do not demonstrate a clinically important
reduction in flow-mediated dilation. Therefore, FMD% is not
useful as an outcome measure in trials examining the effects of
exercise on OSA.
c) Weight-loss surgery patients with OSA are willing to take part in
a supervised exercise-based RCT prior to surgery to improve
their symptoms of OSA, quality of life and physical fitness.
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Future research should:
a) Examine whether a slow-walking speed question can improve
the diagnostic utility of the STOP-Bang tool in the general adult 
population.
b) Employ PSG and larger clinical sample sizes to further
investigate whether the addition of a slow-walking speed
question can improve the diagnostic utility of the STOPANG tool
in weight-loss surgery patients.
c) Focus on the conduct of high quality RCTs using larger and more 
diverse sample groups and longer research timeframes to
advance the evidence base pertaining to the effects of exercise
on OSA in adults.
d) Progress the protocol for a feasibility RCT examining the benefits 
of exercise for obese people with OSA who undergo weight-loss 
surgery into the next research phase.
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         Appendix Eight: Ethical approval for STOP-Bang work
PRIVATE AND CONFIDENTIAL
Direct Line: 01642 384124
13th May 2014
Greg Atkinson
School of Health & Social Care 
Teesside University
Dear Greg
Study No R071/14 - Does an exercise-related question improve the STOP-Bang's diagnostic utility?
Researcher: Sophie Suri.  Supervisor: Greg Atkinson.
Thank you for submitting an application for Ethical Clearance via a Research Ethics Release Form. 
I have reviewed and approved your application on 12th May 2014 and your study may proceed as it was
described in your application pack.
Please note:
Where applicable, your study may only proceed when you have also received written approval from any other
ethical committee (e.g. NRES) and operational / management structures relevant (e.g. Local NHS R&D). If 
applicable please forward to me a copy of the approval letter from NRES before proceeding with the study.
In all cases, should you wish to make any substantial amendment to the protocol detailed, or supporting
documentation included, in your approved application pack (other than those required as urgent safety
measures) you must obtain written approval for those, from myself and all other relevant bodies, prior to 
implementing any amendment. Details of any changes made as urgent safety measures must be provided in
writing to myself and all other relevant bodies as soon as possible after the relevant event; the study should not
continue until written approval for those changes has been obtained from myself and all other relevant bodies.
On behalf of the School of Health & Social Care Research Governance and Ethics Committee please accept my
best wishes for success in completing your study.
Yours sincerely
Dr. Alasdair MacSween
Chair
Research Governance and Ethics Committee
School of Health & Social Care
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     Appendix Nine: R and D approval for STOP-Bang
k 
Research & Development / Academic Division
Academic Centre
The James Cook University Hospital
Marton Road
Middlesbrough
TS4 3BW
www.southtees.nhs.uk
Tel: 01642 854089
Email: researchdevelopment@stees.nhs.uk
15th May 2014
Sophie Suri
Phd Student
Teesside University
Parkside West
Middlesbrough
TS1 3BA
Dear Sophie
Re: SURI – 150514 - Does an exercise-related question improve the STOP-
Bang's diagnostic utility?
Thank you for submitting your application form to Research and Development. 
Following review, it has been concluded that your work falls into the category of Service 
Evaluation and poses no unacceptable governance or ethical issues. 
Therefore, R&D has approved your Service Evaluation and wishes you well with your study.
Kind regards.
Mr A Owens
Research & Development Director
GMC 3485934
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      Appendix 12: Public involvement questionnaire
Individualized exercise training before and after bariatric
surgery in patients with obstructive sleep apnoea: A
feasibility study
Patient Sex: Male/Female
Patient referral pathway: Specialist Weight Management /
Bariatric
Teesside University and South Tees Hospitals NHS Foundation
Trust (STHNHSFT) are working together to develop a research
study to explore the possibility of taking some exercise prior to
and after weight management surgery when a person has also
been diagnosed with sleep apnoea.
We are seeking your views, which will be invaluable in helping us
to design a future research project. Opinions of patients are very
important in ensuring research studies are of high quality.
Therefore, we would be very grateful if you could take a few
minutes to complete the following questions regarding aspects of
a potential study. There are no right, or wrong, answers. Rather
we are seeking your opinion about the best way to conduct this
research.
Our future study will involve people who have been given a date
for weight management surgery and have also been diagnosed
with “sleep apnoea”, whereby breathing is very difficult during
sleep. We want to help this group of people to do some exercise
before and after their surgery because we believe this will help
them cope with the surgery, reduce the days spent in hospital
after surgery and improve sleep apnoea symptoms. We would
appreciate your views on how easy or difficult you think it would
be to participate in such a study.
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Your help
The following questions will be asked by Sophie Suri, who is
undertaking a postgraduate degree at Teesside University on this
topic of sleep apnoea and exercise.
1. How important do you think increasing your levels of
exercise and fitness might be for improving your current
health status?
Very important
Important
Somewhat important
Not important at all
2. How would you feel about doing some supervised exercise
lasting for a maximum of 1 hour, twice a week, at Teesside
University if your travel expenses were paid for?
Fine
A little Concerned
Very Concerned
I wouldn’t do it
3. How would you feel if this exercise was done in short
“chunks” lasting 30-60 seconds where you would become
out of breath but then there would be some rest periods in
between?
Fine
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A little Concerned
Very Concerned
I wouldn’t do it
4. Would you be willing to keep a written log of how much
physical activity/exercise you do during every-day activities?
Yes
No
5. Would you be willing to wear a pedometer type tracker
(worn on the waist) to measure how much physical
activity/exercise you do during every-day activities?
Yes
No
6. Anyone who is involved in this study would have about a
33% chance of being allocated to a no-exercise “control”
group rather than the group who receive the exercise
training. Here, you would receive all the treatment you would
normally get, but you would not be given any supervised
exercise. However, health measurements would be obtained
from you at various times before and after your surgery.
Would this affect your willingness to be involved in the
study?
Yes
No
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7. Which health measures (you can choose more than 1) would
you want to improve in the study?
Symptoms of sleep apnoea
Length of hospital stay after surgery
Exercise capacity (fitness)
Your weight
Health related quality of life (including; feelings of tiredness,
feelings of being in control and feelings of anxiety and/or
depression)
Physical activity (how active you are)
8. During a study, feedback from patients about the exercise
programme is very important. How would you feel most
comfortable providing us with this information if you were in
this position?
Interview (a one on one informal discussion with the
researcher)
Telephone Interview (the researcher will phone you at a
convenient time)
Focus group (a group discussion with other patients and
the researcher)
Survey (a written survey completed at your postoperative
clinic appointment)
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9. Hypothetically, would you be interested in participating in
a study of this kind?
Yes
No
If NO, could you explain reasons why you would not want to
participate?
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!
Do you have any suggestions regarding questions we could ask
in the interview/focus group/surveys to determine your thoughts
about the exercise completed during the study?
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!
If you have any further suggestions or comments about issues we
have not covered please feel free to write these below
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 
!!!!!!!!!!!!!!!!!!!!
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On behalf of the team at Teesside University and at STHNHSFT,
thank you for taking the time to complete this form. Your opinions
are very valuable in improving the quality of the research
conducted at JCUH.
Kind regards
Prof. Greg Atkinson
Professor of Health Sciences Research
Teesside University
Prof. Gerard Danjoux
Consultant (Sleep Medicine and Anaesthesia)
South Tees Hospitals NHS Foundation Trust 
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